1. 106539689 一种连续性的液体凝固的智能滴丸机
CN
29.03.2017
A61J 3/06 Loading...
A61J 3/06
Loading...
201610807423.3
天士力制药集团股份有限公司
闫凯境
A61J 3/06
Loading...
本发明提供一种连续性的液体凝固的智能滴丸机，包括：依次通过输送管道连接的一喂料装置、一化料装置、一均质装置、一滴制装置及一脱油装置。以高速离心方式脱除滴丸附着的冷却液，通过对各生产环节的装置进行优化调整，使各组成装置之间衔接紧凑，可实现连续性生产作业，能够保证滴丸产量的同时减小设备整机的占地面积。
2. 106539690 一种液体冷却滴丸的连续智能制备方法
CN
29.03.2017
A61J 3/06 Loading...
A61J 3/06
Loading...
201610807442.6
天士力制药集团股份有限公司
闫凯境
A61J 3/06
Loading...
本发明提供一种液体冷却滴丸的连续智能制备方法，包括如下步骤：1）喂料，将多种物料分别称重、输送；2）化料，对步骤1）输送的所述物料通过分级加热、混合，得到混合物料，所述混合物料中有效成分RSD≤5%；3）均质，对步骤2）得到的混合物料进行加压、升温，得到有效成分RSD≤5%的均质物料；4）滴制，将步骤3）得到的均质物料进行振动滴制后，得到滴丸，滴丸投入冷却液进行冷却后输送；5）脱油，通过倾斜离心方式脱除步骤4）输送的滴丸表面的冷却液。不仅缩短整个制备过程经过的时间，确保滴丸产品更具稳定性和均匀性，且通过采用高速离心的方式合理对滴丸脱油，即防止滴丸被污染，又提高冷却液的循环利用率。
3. WO/2017/045609 INTELLIGENT CONTINUOUS MANUFACTURING METHOD VIA LIQUID COOLING OF DRIPPING PILLS
WO
23.03.2017
A61J 3/06 Loading...
A61J 3/06
Loading...
PCT/CN2016/099018
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Kaijing
A61J 3/06
Loading...
An intelligent continuous manufacturing method via liquid cooling of dripping pills comprises the following steps: (1) feeding: weighing and transferring multiple materials respectively; (2) material combining: performing staged heating on the materials transferred in step (1), and mixing the same to obtain a material mixture, wherein an RSD of an effective ingredient in the material mixture ≤ 5%; (3) homogenizing: pressurizing the material mixture obtained in step (2), and increasing the temperature, so as to obtain a homogenized material having the RSD of the effective ingredient in the material mixture ≤ 5%; (4) dripping: performing vibration dripping on the homogenized material obtained in step (3) to obtain dripping pills, delivering the dripping pills into a cooling liquid to be cooled and then transferred; and (5) de-oiling: removing the cooling liquid on surfaces of the dripping pills obtained in step (4) via tilting centrifugation. The manufacturing method not only shortens the manufacturing process, but also ensures the dripping pill product to be more stable and homogeneous. In addition, high-speed centrifugation is used to reasonably de-oil the dripping pills to prevent contamination of the dripping pills and improve the circulation utilization rate of the cooling liquid.
4. WO/2017/045610 INTELLIGENT DRIPPING PILL MACHINE FOR CONTINUOUS LIQUID SOLIDIFICATION
WO
23.03.2017
A61J 3/06 Loading...
A61J 3/06
Loading...
PCT/CN2016/099019
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Kaijing
A61J 3/06
Loading...
An intelligent dripping pill machine for continuous liquid solidification comprises: a feeding device (1), a material combining device (2), a homogenizing device (3), a dripping device (4) and a de-oiling device (5) sequentially connected via a transmission channel. The intelligent dripping pill machine removes, via high-speed centrifugation, a cooling liquid attached to dripping pills, and each component device is connected compactly, thereby achieving a continuous manufacturing operation, and reducing an occupied space of the devices as a whole while ensuring the yield of the dripping pills.
5. 106511460 一种治疗肝纤维化的中药组合物
CN
22.03.2017
A61K 36/537 Loading...
A61K 36/537
Loading...
102015000581973
天士力制药集团股份有限公司
周水平
A61K 36/537
Loading...
本发明公开一种中药组合物，其是由下述重量份比的提取物组成：丹参提取物与三七提取物的配比为10:1～1:16，该中药组合物具有预防或治疗肝纤维化药物中的应用。
6. 103372139 含有生脉饮有效成分的药物组合物
CN
22.03.2017
A61K 36/8968 Loading...
A61K 36/8968
Loading...
201210123905.9
天士力制药集团股份有限公司
王玉
A61K 36/8968
Loading...
本发明涉及一种含有生脉饮有效成分的药物组合物，该组合物含有红参总皂苷15‑35重量份，麦冬总多糖150‑250重量份，五味子木脂素2‑4重量份。
7. 104418744 一种新的丹酚酸化合物T、其制备方法和用途
CN
01.03.2017
C07C 69/732 Loading...
C07C 69/732
Loading...
102014000343137
天士力制药集团股份有限公司
周水平
C07C 69/732
Loading...
本文涉及医药领域。具体涉及一种结构式(I)所述的丹酚酸T、其手性异构体、其制备方法、含有该化合物的医药组合物、抗氧化剂、自由基清除剂以及该化合物的用途。
8. 103675111 肾炎清片中土大黄主要成分含量的检测方法
CN
15.02.2017
G01N 30/02 Loading...
G01N 30/02
Loading...
102012000327760
天士力制药集团股份有限公司
周桂荣
G01N 30/02
Loading...
本发明公开了一种肾炎清片中土大黄主要成分含量的检测方法，采用反相色谱法测定肾炎清片中大黄素、大黄酚和大黄素甲醚的含量，色谱条件采用C18柱，流动相为甲醇—0.1%磷酸溶液，检测波长210‑320nm。该方法操作简便、灵敏度高，重现性好，可为肾炎清片质量标准的制定提供了依据。
9. 104062392 一种测定血浆中丹酚酸L的方法
CN
15.02.2017
G01N 30/89 Loading...
G01N 30/89
Loading...
102013000093029
天士力制药集团股份有限公司
李伟
G01N 30/89
Loading...
本发明涉及一种药物在血浆中的含量的方法，步骤如下：（1）样品处理：取血浆样品，加入酸溶液和内标溶液适量，混合；之后加入有机溶剂混合进行萃取；上述混合液离心后取有机溶剂层，在水浴下吹干，然后用液相流动相复溶后离心，取上清液进样测定；（2）液相分离：液质联用仪的液相部分采用反相硅胶色谱柱作为分离介质，进样后用固定比例流动相进行等度洗脱，使干扰物、待测物和内标获得初步分离；其中流动相A相选自甲酸水溶液、乙酸水溶液、三氟乙酸水溶液或醋酸铵水溶液，B相选自乙腈或甲醇，A相占整个流动相的30‑90%；（3）质谱检测：液质联用仪的质谱部分按照设定的离子化条件，采用SRM扫描功能检测血浆样品中丹酚酸L和内标的含量。
10. 106266002 一种治疗高尿酸血症的中药组合物
CN
04.01.2017
A61K 36/718 Loading...
A61K 36/718
Loading...
102015000257169
天士力制药集团股份有限公司
李瑞明
A61K 36/718
Loading...
本发明涉及一种治疗高尿酸血症的中药组合物，所述中药组合物是用以下重量配比的中药为原料药制备而成：威灵仙15～60份、秦皮10～50份、大黄4～20份、黄连2～10份。
11. 106265077 一种中药浸膏雾化分散工艺及其制剂
CN
04.01.2017
A61J 3/00 Loading...
A61J 3/00
Loading...
102015000290209
天士力制药集团股份有限公司
章顺楠
A61J 3/00
Loading...
本发明提供了一种中药分散物的制备方法，包括制浆和制分散物两个步骤。本发明还提供了利用这种方法制备养血清脑制剂及其他制剂的方法。此外，本发明还提供了利用这些方法制成的制剂。利用本发明提供的方法制得的制剂具有生产周期短、节约能耗、加快生产效率、载药量高且载药范围较宽等优点，可以通用于多个品种的生产制备。
12. 103091454 复方丹参滴丸生产过程的总有机碳检测方法
CN
14.12.2016
G01N 33/00 Loading...
G01N 33/00
Loading...
102011000333099
天士力制药集团股份有限公司
王建平
G01N 33/00
Loading...
本发明涉及一种复方丹参滴丸生产过程的总有机碳检测方法，该方法步骤如下：步骤1，取样；步骤2，样品处理；步骤3，样品检测。其中，步骤1中取样为擦拭取样或淋洗水取样；其中，步骤2所述样品处理，方法如下：擦拭样品：用移液枪精密移取40ml超纯水至装有擦拭样品的TOC小瓶中，振摇1min使棉签上的物质充分溶解，样品溶解后溶液无色，待检，淋洗水：振摇盛有淋洗水的TOC样品瓶1min，样品应无色，待检；其中，步骤3所述样品检测，方法如下：检测前，将样品再次振摇，使溶液混匀，将样品瓶放入TOC测定仪进行检测，计算TOC值。
13. 106153792 一种香加皮的指纹图谱及其质量检测方法
CN
23.11.2016
G01N 30/88 Loading...
G01N 30/88
Loading...
102015000128555
天士力制药集团股份有限公司
鄂秀辉
G01N 30/88
Loading...
本发明涉及一种香加皮的有效成分测定方法，其特征在于，所述方法包括以下步骤：(1)对照品溶液的制备：称取绿原酸、4-甲氧基水杨醛、杠柳毒苷对照品，加甲醇制得混合对照品溶液；(2)供试品溶液的制备：取香加皮干燥粉碎，过筛，精密称取，加入甲醇溶液，提取20-50min，放冷，离心，取上清液，即得供试品溶液；(3)测定法：吸取混合对照品溶液和供试品溶液，注入超高效液相色谱仪，得到色谱图，根据色谱图计算供试品中相应成分的含量。
14. 106033075 一种益心复脉颗粒中黄芪甲苷含量测定方法
CN
19.10.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201510110146.6
天士力制药集团股份有限公司
侯春莲
G01N 30/02
Loading...
本发明涉及一种中药制剂中有效成分的含量测定方法，特别涉及一种益心复脉颗粒中黄芪甲苷含量测定方法，所述方法，包括如下步骤：对照品溶液的制备：取黄芪甲苷对照品适量，加入含水甲醇或流动相制成含有黄芪甲苷0.16～0.24mg1/ml的溶液即可；供试品溶液的制备：取益心复脉颗粒，用浓度为2～5％碱水溶液提取，提取液过固相萃取柱，用甲醇洗脱即可；测定法：将上述对照品溶液和对照品溶液各5～20μl注入高效液相色谱仪中。
15. 105983015 一种含有水飞蓟宾、VE的药物组合物
CN
05.10.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
102016000158593
天士力制药集团股份有限公司
孙鹤
A61K 36/82
Loading...
本发明公开了一种药物组合物，其是由下述重量比的原料药制成：水飞蓟宾8.75-60份，磷脂15-65份，普洱茶提取物25-200份，维生素E6.25-40份，该药物具有治疗非酒精性脂肪肝的作用。
16. 105983016 一种含有水飞蓟宾的药物组合
CN
05.10.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
102016000158689
天士力制药集团股份有限公司
吴迺峰
A61K 36/82
Loading...
本发明公开一种药物组合，是由水飞蓟宾-磷脂复合物制剂和普洱茶/茶制品按照重量比为0.5-2.5:0.3-10组成，其中水飞蓟宾胶囊-磷脂复合物制剂和普洱茶/茶制品单独包装，其对非酒精性脂肪肝有显著疗效。
17. 105983017 一种含有水飞蓟宾、左旋肉碱的药物组合物
CN
05.10.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
102016000159763
天士力制药集团股份有限公司
孙鹤
A61K 36/82
Loading...
本发明公开了一种药物组合物，其是由下述重量比的原料药制成：水飞蓟宾8.75‑60份，磷脂15‑65份，普洱茶提取物25‑150份，左旋肉碱10.425‑60份；该药物具有治疗非酒精性脂肪肝的作用。
18. 105983013 一种含有水飞蓟宾、葛根提取物的药物组合物
CN
05.10.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
102016000157921
天士力制药集团股份有限公司
闫希军
A61K 36/82
Loading...
本发明公开了一种药物组合物，其是由下述重量比的原料药制成：水飞蓟宾8.75‑60份，磷脂15‑65份，普洱茶提取物25‑200份，葛根提取物5‑50份；该药物具有治疗非酒精性脂肪肝的作用。
19. 105983018 一种含有水飞蓟宾的药物组合物
CN
05.10.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
102016000159764
天士力制药集团股份有限公司
吴迺峰
A61K 36/82
Loading...
本发明公开了一种含有水飞蓟宾的药物组合物，其是由下述重量比的原料药制成：水飞蓟宾8.75‑60份，磷脂15‑65份，普洱茶提取物25‑200份；该药物具有治疗非酒精性脂肪肝的作用。
20. 105983014 一种含有水飞蓟宾、VE和左旋肉碱的药物组合物
CN
05.10.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
102016000157922
天士力制药集团股份有限公司
孙鹤
A61K 36/82
Loading...
本发明公开了一种药物组合物，其是由下述重量比的原料药制成：水飞蓟宾8.75‑60份，磷脂15‑65份，普洱茶提取物25‑200份，维生素E6.25‑40份，左旋肉碱8.3‑60份；该药物具有治疗非酒精性脂肪肝的作用。
21. WO/2016/150375 PHARMACEUTICAL COMPOSITION CONTAINING SILIBININ
WO
29.09.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
PCT/CN2016/077034
TASLY PHARMACEUTICAL GROUP CO., LTD.
WU, Naifeng
A61K 36/82
Loading...
Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipin, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.
22. WO/2016/150380 PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN
WO
29.09.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
PCT/CN2016/077039
TASLY PHARMACEUTICAL GROUP CO., LTD.
WU, Naifeng
A61K 36/82
Loading...
A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid compound preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid compound capsule preparation and the Pu'er tea/tea product are separately packaged.
23. WO/2016/150377 PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN, VE AND L-CARNITINE
WO
29.09.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
PCT/CN2016/077036
TASLY PHARMACEUTICAL GROUP CO., LTD.
SUN, He
A61K 36/82
Loading...
A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.
24. WO/2016/150379 PHARMACEUTICAL COMPOSITION CONTAINING SILIBININ AND PUERARIA ROOT EXTRACT
WO
29.09.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
PCT/CN2016/077038
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 36/82
Loading...
Disclosed are a pharmaceutical composition for treating non-alcoholic fatty liver and a method for preparing same. The composition is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipin, 25-200 parts of Pu'er tea extract, and 5-50 parts of pueraria root extract.
25. WO/2016/150378 PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND L-CARNITINE
WO
29.09.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
PCT/CN2016/077037
TASLY PHARMACEUTICAL GROUP CO., LTD.
SUN, He
A61K 36/82
Loading...
A pharmaceutical composition for treating non-alcoholic fatty liver diseases. The pharmaceutical composition is prepared from 8.75-60 parts by weight of silybin, 15-65 parts by weight of phospholipid, 25-150 parts by weight of a Pu'er tea extract, and 10.425-60 parts by weight of L-carnitine.
26. WO/2016/150376 PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND VE
WO
29.09.2016
A61K 36/82 Loading...
A61K 36/82
Loading...
PCT/CN2016/077035
TASLY PHARMACEUTICAL GROUP CO., LTD.
SUN, He
A61K 36/82
Loading...
A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.
27. 103059149 一种PRP多糖提取方法
CN
31.08.2016
C08B 37/00 Loading...
C08B 37/00
Loading...
102011000318119
天士力制药集团股份有限公司
李军强
C08B 37/00
Loading...
本发明涉及B型流感嗜血杆菌聚核糖基核糖醇磷酸酯纯化方法，该方法包括以下步骤：(1)从B型流感嗜血杆菌发酵液中去除菌体得到发酵液上清；(2)从发酵液上清中去除核酸和蛋白，得到PRP多糖。
28. 105823830 一测多评法测定益心复脉颗粒中丹酚酸B和五味子醇甲含量的方法
CN
03.08.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
102015000013254
天士力制药集团股份有限公司
侯春莲
G01N 30/02
Loading...
本发明涉及一种一测多评法测定益心复脉颗粒中丹酚酸B和五味子醇甲含量的方法。具体为制备益心复脉颗粒供试品溶液和五味子醇甲对照品溶液，将其分别注入高效液相色谱仪，在本发明特定的色谱条件下采用梯度洗脱，测定五味子醇甲的含量，通过一测多评法，利用丹酚酸B与五味子醇甲之间的相对校正因子计算益心复脉颗粒中丹酚酸B的含量。本发明建立的一测多评法进一步提高了该产品的质量控制水平，同时节省检测成本。
29. 105816422 一种水飞蓟宾注射剂及其制备方法
CN
03.08.2016
A61K 9/08 Loading...
A61K 9/08
Loading...
201510001635.8
天士力制药集团股份有限公司
陈建明
A61K 9/08
Loading...
本发明的一种水飞蓟宾注射剂，是结合水飞蓟宾固有的理化性质，优选出了与之匹配的处方组成与用量，即是由水飞蓟宾、磺丁基醚-β-环糊精、注射用有机溶媒组成，必要时还可含有助溶剂、冻干支撑剂、pH调节剂、注射用水等。本制剂具有安全、稳定、载药量高的特点，从根本上克服了水飞蓟宾现有口服制剂生物利用度低的不足，有望进一步最大化的发挥水飞蓟宾的药理作用，为水飞蓟宾的临床应用与研究奠定了基础。
30. 103623404 一种B型流感嗜血杆菌多糖结合疫苗的制备方法
CN
03.08.2016
A61K 39/385 Loading...
A61K 39/385
Loading...
102012000311027
天士力制药集团股份有限公司
李军强
A61K 39/385
Loading...
本发明公开了一种B型流感嗜血杆菌多糖结合疫苗的制备方法，制备方法为:A.B型流感嗜血杆菌的多糖提取物，室温下用超纯水或注射用水溶解PRP多糖至20mg/ml，按照PRP与CDAP的质量比为1的条件下加入CDAP，维持1.5min。0.3M NaOH调节pH至9.5，维持3min。按照ADH与PRP多糖质量比为4：1的条件，加入固体ADH。0.3M NaOH调节pH至9.5，维持1h。2?8℃，0.2M NaCl透析；B.透析后的PRP?AH与20mg/ml TT溶液以质量比1：2混合。0.1M HCL调节pH至5.0，然后按照EDAC与PRP质量比为10：1的比例加入固体EDAC，室温下维持pH5.060min，0.3M NaOH调节pH至7.5反应30min。
31. 105784894 一种用于中药的农药残留检测方法
CN
20.07.2016
G01N 30/88 Loading...
G01N 30/88
Loading...
102014000827302
天士力制药集团股份有限公司
佟玲
G01N 30/88
Loading...
本发明涉及一种用于现代中药制剂的农药残留检测方法，本发明建立了包含有机氯类、有机磷类、二甲酰亚胺类、拟除虫菊酯类等103种农药残留的GC-MS/MS检测方法，试验中采用乙酸乙酯作为提取溶剂，氨基柱净化，以中药基质加标溶液进行测定，本方法为中药安全性提供了有效、准确的质量控制方法。
32. WO/2016/110193 SILYBIN INJECTION AND PREPARATION METHOD THEREFOR
WO
14.07.2016
A61K 31/357 Loading...
A61K 31/357
Loading...
PCT/CN2015/098713
TASLY PHARMACEUTICAL GROUP CO., LTD.
CHEN, Jianming
A61K 31/357
Loading...
A silybin injection contains silybin, sulfobutyl ether-β-cyclodextrin, an organic solvent for injection, and may further contain a co-solvent, a lyophilization proppant, a pH regulator, water for injection and the like.
33. 103364496 同时测定柴胡浸膏中四种柴胡皂苷含量的方法
CN
06.07.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201210100704.7
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
柴胡浸膏皂苷类成分的高效液相色谱检测方法，供试品采用固相萃取柱预处理，色谱条件为采用C18色谱柱，流动相为乙腈-水梯度洗脱，检测器为二极管阵列检测器。
34. 105708797 一种取代桂皮酰胺衍生物的自乳化载药系统
CN
29.06.2016
A61K 9/107 Loading...
A61K 9/107
Loading...
201410738043.X
天士力制药集团股份有限公司
赵锦花
A61K 9/107
Loading...
本发明涉及一种取代桂皮酰胺衍生物的自乳化载药系统，本发明通过采用自乳化载药系统方式，通过一系列筛选选取适合的油相、表面活性剂和助表面活性剂及其与药物的配比,明显提高了取代桂皮酰胺衍生物的溶解度和生物利用度，在胃肠道轻微搅动下形成易于吸收的小液滴，这些小液滴可以在体液(例如血液和淋巴液)中分散，其增大的表面积显著提高药物的吸收度，自乳化载药系统溶液可灌入胶囊(软胶囊和硬胶囊)、玻璃瓶等后用于商业销售。
35. 105708846 三七皂苷R1在制备治疗心肌肥厚药物中的应用
CN
29.06.2016
A61K 31/704 Loading...
A61K 31/704
Loading...
201410727976.9
天士力制药集团股份有限公司
韩晶岩
A61K 31/704
Loading...
本发明属于药学领域，涉及三七皂苷R1以及含有该成分的药物在治疗心肌肥厚方面的作用。
36. 105708828 咖啡酸在制备治疗肝微循环障碍和肝损伤药物中的应用
CN
29.06.2016
A61K 31/192 Loading...
A61K 31/192
Loading...
201410727980.5
天士力制药集团股份有限公司
韩晶岩
A61K 31/192
Loading...
本发明涉及咖啡酸在制备治疗肝微循环障碍和肝损伤药物中的应用。本发明通过咖啡酸对肝缺血再灌注大鼠的一系列观察，发现咖啡酸可以通过改善肝表面血流量；通过抑制AMPKα磷酸化及PKCδ膜转位、抑制NADPH亚基P41和P47的膜转位以及抑制NADPH来源的过氧化物；通过提高肝缺血再灌注大鼠线粒体呼吸链活性，减少线粒体损伤引起的过氧化物的产生，从而增加ATP的产生；通过抑制缺血再灌注引起的肝细胞凋亡；通过减轻缺血再灌注引起的肝细胞内细胞骨架的损伤等作用途径，在治制备治疗肝微循环障碍和肝损伤药物中提供了新的应用。
37. 105699500 一种超高效液相色谱法测定藿香正气滴丸中7种成分含量的方法
CN
22.06.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201410707809.8
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
本发明涉及一种超高效液相色谱法测定藿香正气滴丸中7种成分含量的方法。本方法可在20min内完成一次色谱分析，被测定的7种成分色谱峰均有良好的分离度，方法精密度、重复性的RSD均小于2.0％；在室温条件下24h内稳定；各成分均有较宽的线性范围和良好的线性关系(r≥0.9995)；平均加样回收率97.5-101.4％，RSD均小于2.0％。本发明的方法操作简便，测定结果准确可靠，可用于藿香正气滴丸的质量控制。
38. 102998375 一种同时检测养血清脑颗粒中阿魏酸与芍药苷含量的方法
CN
20.04.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201110269072.2
天士力制药集团股份有限公司
高展
G01N 30/02
Loading...
本发明涉及医药领域，具体涉及一种同时检测养血清脑颗粒中阿魏酸与芍药苷的含量测定方法本发明所述的质量检测方法，本发明的芍药苷与阿魏酸的含量测定方法，包括对照品和供试品溶液的制备步骤和测定步骤，其中，对照品溶液的制备方法如下：取芍药苷对照品，加甲醇溶解即得，取阿魏酸对照品加甲醇溶解即得，其中，养血清脑颗粒供试样品溶液的制备方法如下：取养血清脑颗粒用碱性溶液溶解，溶液通过大孔吸附树脂洗脱收集甲醇洗脱液。
39. 105486764 一种坤灵丸的气相指纹图谱的分析方法及其应用
CN
13.04.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201410484066.2
天士力制药集团股份有限公司
阚红玉
G01N 30/02
Loading...
本发明提供了一种坤灵丸的气相指纹图谱分析方法，所述方法包括：坤灵丸标准气相指纹图谱的建立、待测坤灵丸气相指纹图谱的测定和相似性比较判定等步骤。本发明通过尝试多种程序升温条件，最终确定了坤灵丸的气相指纹图谱分析的色谱条件，考察确定了10个共有峰的对照气相指纹图谱，具有方法简便、速度快、重现性好等特点。所建立的标准气相指纹图谱经方法学验证满足相关要求，适用性强，能够更全面的反映产品质量状况，为质量控制及制定标准提供了重要依据。
40. 105486763 一种坤灵丸的质量检测方法及其应用
CN
13.04.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201410484061.X
天士力制药集团股份有限公司
阚红玉
G01N 30/02
Loading...
本发明提供了一种坤灵丸的质量检测方法，所述方法包括：坤灵丸的鉴别和含量测定；其中鉴别方法采用薄层色谱法对坤灵丸的中药组成成分进行鉴别，包括对牡丹皮、当归-川芎-藁本、延胡索、白芍、红参、香附的鉴别；含量测定方法采用高效液相色谱法对坤灵丸中有效成分丹皮酚的含量进行测定，本发明具有方法简便、速度快、重现性好等特点，所建立的鉴别及含量测定方法经方法学验证满足相关要求，适用性强，能够更全面的反映产品质量状况，为质量控制及制定标准提供了重要依据。
41. 105486762 一种坤灵丸的高效液相指纹图谱检测方法
CN
13.04.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201410482791.6
天士力制药集团股份有限公司
阚红玉
G01N 30/02
Loading...
本发明提供了一种坤灵丸的高效液相指纹图谱检测方法，所述方法包括：坤灵丸标准指纹图谱的建立、待测坤灵丸指纹图谱的测定和相似性比较判定等步骤。本发明通过尝试多种不同洗脱条件，最终确定了坤灵丸的指纹图谱分析的色谱条件，考察确定了8个共有峰的对照指纹图谱，具有方法简便、速度快、重现性好等特点，所建立的标准指纹图谱经方法学验证满足相关要求，适用性强，能够更全面的反映产品质量状况，为质量控制及制定标准提供了重要依据。
42. 105467022 一种与神经元损伤相关的差异表达蛋白的分析方法
CN
06.04.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201410452370.9
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
本发明涉及一种与神经元损伤相关的差异表达蛋白的分析方法，所述方法，包括以下步骤：步骤1.斑马鱼脑部和中枢神经损伤模型的构建并分组；步骤2.药物组用药物处理；步骤3.各组提取总蛋白；步骤4.质谱上样分析；步骤5.生物信息学分析。
43. 105467023 一种UPLC测定穿心莲药材指纹图谱及四种二萜内酯的方法
CN
06.04.2016
G01N 30/02 Loading...
G01N 30/02
Loading...
201410452373.2
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
本发明涉及一种超高效液相色谱法测定穿心莲药材指纹图谱和穿心莲四种二萜内酯的含量测定方法。制备穿心莲药材供试品溶液，将供试品注入超高效液相色谱仪，在本发明特定的色谱条件下采用梯度洗脱，得到穿心莲药材指纹图谱和穿心莲内酯、脱水穿心莲内酯、新穿心莲内酯、去氧穿心莲内酯的含量。综合其指纹图谱和四种二萜内酯类成分含量测定数据，为判断穿心莲药材真伪、保证穿心莲药材的内在质量、考察稳定性和一致性提供依据，并且在保证穿心莲药材临床的合理应用具有重要意义。
44. 105451734 穿心莲内酯在制备炎症性肠病的药物中的应用、穿心莲内酯肠溶靶向微丸及其制备方法
CN
30.03.2016
A61K 31/365 Loading...
A61K 31/365
Loading...
201480044529.1
天士力制药集团股份有限公司
孙鹤
A61K 31/365
Loading...
本发明涉及一种穿心莲内酯肠溶靶向微丸及其制备方法，此外，本发明还涉及穿心莲内酯、穿心莲内酯肠溶靶向微丸在制备治疗炎症性肠病的药物中的用途。
45. 105311045 人参皂苷Rg1在制备预防和/或治疗心肌缺血的药物中的应用
CN
10.02.2016
A61K 31/704 Loading...
A61K 31/704
Loading...
201410378683.4
天士力制药集团股份有限公司
韩晶岩
A61K 31/704
Loading...
本发明涉及人参皂苷Rg1在制备预防和/或治疗心肌缺血的药物中的应用，所述治疗和预防心肌缺血是人参皂苷Rg1改善心肌能量代谢和心功能、减少心肌梗死面积、改善心脏表面血流量。
46. 105311021 钩藤碱在制备改善血管内皮功能障碍药物中的应用
CN
10.02.2016
A61K 31/437 Loading...
A61K 31/437
Loading...
201410378777.1
天士力制药集团股份有限公司
韩晶岩
A61K 31/437
Loading...
本发明涉及一种药物的新应用，特别涉及钩藤碱(Rhy)在制备改善与高血压相关的肾脏血管内皮舒张功能障碍药物中的应用。本发明应用钩藤碱对自发性高血压大鼠(SHRs)的肾动脉进行了孵育，应用多通道的小血管张力测定仪评估了钩藤碱对肾动脉的内皮依赖性血管舒张的改善作用，并应用蛋白质免疫印迹法和NO检测试剂盒检测了钩藤碱是通过何种途径发挥改善与高血压病相关的肾脏血管内皮舒张功能障碍作用的。研究发现钩藤碱孵育可以时间和浓度依赖性的改善SHRs肾动脉内皮依赖性的血管舒张功能；钩藤碱的这种作用是通过激活Src-PI3K/Akt-eNOS通路增加eNOS活性而实现的。
47. 105277643 一种用于复方丹参滴丸的一测多评检测方法
CN
27.01.2016
G01N 30/88 Loading...
G01N 30/88
Loading...
201410342437.3
天士力制药集团股份有限公司
佟玲
G01N 30/88
Loading...
本发明涉及一种用于复方丹参滴丸的一测多评检测方法，所述方法包含6种酚酸类成分的UPLC一测多评含量测定方法，试验中采用原儿茶醛作为单个标定物，以外标加校正因子法进行测定，本方法为复方丹参滴丸药效物质提供了有效、准确的质量控制方法。
48. 105253388 一种加装图像采集装置和集成收集装置的灌装机
CN
20.01.2016
B65B 57/04 Loading...
B65B 57/04
Loading...
201410283371.5
天士力制药集团股份有限公司
李常洪
B65B 57/04
Loading...
本发明提供一种加装图像采集装置和集成收集装置的灌装机，包括灌装机主体，包括落药口；计量盘，均布若干计量部；所述落药口上对应有落药工位，所述落药工位两侧分别有布药工位及落药后工位，三个工位对应计量盘上任意三个相邻的计量部位置；计量盘上方安装有图像采集装置，用以采集布药工位及落药后工位上图像信息，并向控制单元传输图像信息；还包括集成收集装置，包括收集传送带及剔除装置；所述控制单元自动判断识别不合格药袋；并控制剔除装置剔除不合格药袋。通过采用适合孔位法计量的计量盘，并加装图像采集装置及集成收集装置，能够实现布药过程中的自动化监测，并实现合格药袋和不合格药袋的独立收集。
49. 105168196 (4-羟基-3-甲氧基苯基)乳酸在治疗心血管疾病中的应用
CN
23.12.2015
A61K 31/192 Loading...
A61K 31/192
Loading...
201410260530.X
天士力制药集团股份有限公司
李伟
A61K 31/192
Loading...
本发明涉及3-(3-甲氧基-4-羟基苯基)乳酸在治疗心血管疾病中的应用，本发明通过对3-(3-甲氧基-4-羟基苯基)乳酸在心血管系统方面的药效活性进行研究，发现其对大鼠急性心肌缺血具有拮抗作用、还具有清除DPPH自由基作用，表明3-(3-甲氧基-4-羟基苯基)乳酸在降低心肌梗塞发生率、抗急性心肌缺血、清除DPPH自由基(DPPH·)的作用和清除超氧阴离子自由基(02-.)作用方面均优于丹参素。
50. 102998411 一种藿香正气滴丸的检测方法
CN
16.12.2015
G01N 30/90 Loading...
G01N 30/90
Loading...
201110269071.8
天士力制药集团股份有限公司
阚红玉
G01N 30/90
Loading...
本发明涉及医药领域，具体涉及一种藿香正气滴丸的质量检测方法包括鉴别方法和含量测定方法，鉴别方法，包括对以下成分的鉴别：A苍术鉴别，B白芷鉴别，C厚朴、广藿香油薄层鉴别，D紫苏叶油鉴别，E陈皮鉴别，F甘草鉴别，G半夏鉴别，鉴别方法采用薄层色谱法，本发明还包括对藿香正气滴丸中的有效成分进行含量测定，其中所述的有效成分为橙皮苷、厚朴酚与和厚朴酚，含量测定方法采用高效液相色谱法。
51. WO/2015/043522 TRIFLUOROMETHYL-CONTAINING AMIDE ALKALOID, MANUFACTURING METHOD AND PHARMACEUTICAL USE THEREOF
WO
02.04.2015
C07C 233/11 Loading...
C07C 233/11
Loading...
PCT/CN2014/087675
TASLY PHARMACEUTICAL GROUP CO., LTD.
ZHOU, Shuiping
C07C 233/11
Loading...
The present invention relates to trifluoromethyl-containing amide alkaloid, a manufacturing method thereof, pharmaceutical combinations containing same, and pharmaceutical use thereof. The trifluoromethyl-containing amide alkaloid of the present invention has a structure of Formula (I). The present invention further comprises pharmaceutical application of derivatives of the alkaloid in treatment and prevention of mental disorder of melancholic depression. In Formula (I), where n is 0, 1, 2 or 3, and when n is 1, 2 or 3, the unit of Formula (II) at least contains one carbon-carbon single bond or one carbon-carbon double bond; X is N; R1 and R1' are the same or different, and are respectively H, C1-C10 linear hydrocarbon, C3-C10 branched hydrocarbon, C3-C10 cyclic hydrocarbon, C1-C10 hydroxyalkyl or N-substituted piperazine derivative; or, R1 and R1' and adjacent X form pyrrolidine, piperidine or hexamethyleneimine; R2 is H, OH, OR4, F, Cl, Br, I, C1-C10 linear hydrocarbon, C3-C10 branched hydrocarbon, CF3, CHF2, CH2F, NO2, NH2, OCF3, OCHF2, OCH2F, -O-C(=O)-R4 or -C(=O)O-R4; R3 is H, OH, OR4, F, Cl, Br, I, C1-C10 linear hydrocarbon, C3-C10 branched hydrocarbon, CF3, CHF2, CH2F, NO2, NH2, OCF3, OCHF2, OCH2F, -O-C(=O)-R4 or -C(=O)O-R4; and R4 is C1-C10 linear hydrocarbon, C3-C10 branched hydrocarbon, C3-C10 cyclic hydrocarbon, C4-C12 cyclic hydrocarbon/alkyl, and C1-C10 hydroxyalkyl.
52. 204233450 液冷滴丸生产线
CN
01.04.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
201420387150.8
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
一种液冷滴丸生产线，包括滴丸系统、液冷循环系统和控制系统，滴丸系统包括化料罐和与其相连的滴头，化料罐与滴头之间设有振动装置，滴头上设有在线监测装置，该装置包括脉冲信号发射机构，脉冲信号发射机构的发射频率与振动装置的振动频率相同，控制系统根据在线监测装置的监测结构控制调节滴制参数。本实用新型结合高频切割滴制，在线实时检测并控制调节滴丸质量，提高产率，拓宽滴丸直径范围；通过在冷却罐罐壁上开设多个切向入口，有效减少液滴在进入冷却罐时冷却液液面对其造成的冲击力；有效消除涌动和脉冲，使滴丸机送料平稳；通过调整出料管线的长径比，增加滴丸冷却时间，保证质量的同时降低能耗。
53. 204233449 滴丸气冷生产线
CN
01.04.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
201420384494.3
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
一种滴丸气冷生产线，包括滴丸系统和气冷循环系统，滴丸系统包括化料罐和与其相连的滴头，气冷循环系统包括：冷却管道，以及与冷却管道连接并对冷却管道制冷的制冷装置，冷却管道外设有夹层，夹层下部通过连通口与冷却管道内部连通；制冷装置包括：冷风制冷装置，其冷风出口与冷却管道底部的冷风进风口相连通；冷阱制冷装置，其包括：装有冷媒的冷媒储罐，以及对冷媒储罐内的冷媒进行制冷的制冷机和换热器，冷媒储罐的冷媒出口与夹层上部设置的冷媒入口相连，冷媒通过冷媒入口输入夹层内，从夹层上部传输至夹层下部并传输到冷却管道内腔中；冷媒在冷却管道的内腔中与冷风同时循环上升，并通过冷却管道顶部排放或回收。
54. 204240707 用于滴丸干燥的流化床
CN
01.04.2015
F26B 3/08 Loading...
F26B 3/08
Loading...
201420384491.X
天士力制药集团股份有限公司
闫希军
F26B 3/08
Loading...
一种用于滴丸干燥的流化床，包括流化床炉体，炉体下方设有物料进料口，在炉体内所述进料口的下方设有气流分布板，常温低湿送风系统的出风管道设置在所述气流分布板的底部，常温低湿送风系统将常温低湿气体经过出风管道送入流化床炉体内，气体穿过气流分布板对内置于炉体内部的物料进行流化干燥处理。本实用新型在现有设备基础上增加了常温低湿送风系统，利用升华原理，通过固-气平衡进行流化干燥，节省能源且工作效率高；同时配合水份在线监测装置，对流化床炉体内滴丸含水程度进行监测，有效控制其含水量；设置在流化床炉体底部中央的喷嘴，通过底喷的方式，使包衣过程稳定，同时有效节省包衣材料；因此，本实用新型结构简单、成本低廉且工作高效。
55. WO/2015/039619 USE OF YANGXUEQINGNAO FORMULATION IN PREPARATION OF MEDICINE FOR TREATING ALZHEIMER'S DISEASE
WO
26.03.2015
A61K 36/804 Loading...
A61K 36/804
Loading...
PCT/CN2014/086915
TASLY PHARMACEUTICAL GROUP CO., LTD.
WU, Naifeng
A61K 36/804
Loading...
Use of a traditional Chinese medicine composition in preparation of medicine for treating Alzheimer's disease (senile dementia). The traditional Chinese medicine composition is prepared from Radix Angelicae Sinensis 6.75%, Rhizoma Chuanxiong 6.75%, Radix Paeoniae Alba 5.4%, Ramulus Uncariae Cum Uncis 13.5%, Caulis Spatholobi 13.5%, Radix Rehmanniae Preparata 5.4%, Semen Cassiae 13.5%, Spica Prunellae 13.5%, Herba Asari 1.34%, Rhizoma Corydalis 6.75% and Concha Margaritifera Usta 13.5%.
56. WO/2015/027929 TRADITIONAL CHINESE MEDICINE COMPOSITION
WO
05.03.2015
A61K 31/704 Loading...
A61K 31/704
Loading...
PCT/CN2014/085362
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 31/704
Loading...
A traditional Chinese medicinal composition and preparation thereof having effect of treating cardiovascular. The traditional Chinese medicinal composition consists of: by weight percentage, phenolic acids 30%-80%, tanshinones ingredient 2%-10% and saponins ingredient 15%-60%.
57. WO/2015/027891 NEW SALVIANOLIC ACID COMPOUND T, PREPARATION METHOD THEREFOR, AND USE THEREOF
WO
05.03.2015
C07C 69/732 Loading...
C07C 69/732
Loading...
PCT/CN2014/085154
TASLY PHARMACEUTICAL GROUP CO., LTD.
ZHOU, Shuiping
C07C 69/732
Loading...
The present abstract relates to the medical field, specifically a salvianolic acid T as described in structural formula (I), a chiral isomer thereof, a preparation method therefor, pharmaceutical compositions, antioxidants, and free radical scavengers thereof, and a use of the compound.
58. 204170103 气冷滴丸生产线
CN
25.02.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
201420383996.4
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
一种气冷滴丸生产线，包括滴丸系统、气冷循环系统和控制系统，滴丸系统包括化料罐和与其相连的滴头，化料罐与滴头之间设有振动装置，振动装置带动滴头上下振动，产生的振动剪切力，将滴头中流出的药液剪切成滴，落入气冷循环系统冷却后形成滴丸，滴头主要包括滴盘，滴盘上设有多个滴孔，滴孔的外围开设有凹形环槽；凹形环槽的内径＝滴孔内径+0.4毫米，外径≥1.5毫米，槽深为0.5-5毫米。本实用新型通过滴孔的外围开设有凹形环槽，防止在黏稠液体高速喷出时，喷孔周围有残余的药液堆积，最终导致喷孔堵塞或影响滴制；结合高频切割滴制，在线实时检测并控制调节滴丸质量，提高产率。
59. 204170104 滴丸气冷循环装置及带有该气冷循环装置的滴丸生产线
CN
25.02.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
201420384171.4
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
本实用新型提供一种滴丸气冷循环装置及带有该气冷循环装置的滴丸生产线，其气冷循环装置包括：冷却管道，以及与冷却管道连接并对冷却管道制冷的制冷装置，冷却管道外设有夹层，夹层下部通过连通口与冷却管道内部连通；制冷装置包括：冷风制冷装置，冷风制冷装置的冷风出口与冷却管道底部的冷风进风口相连通，使冷风在冷却管道内腔中循环上升；冷阱制冷装置包括：装有冷媒的冷媒储罐，以及对冷媒储罐内的冷媒进行制冷的制冷机和换热器，冷媒储罐的冷媒出口与夹层上部设置的冷媒入口相连，冷媒通过冷媒入口输入夹层内，从夹层上部传输至夹层下部并传输到冷却管道内腔中；冷媒在冷却管道的内腔中与冷风同时循环上升，并通过冷却管道顶部排放或回收。
60. WO/2015/018344 APPLICATION OF ANDROGRAPHOLIDE IN THE PREPARATION OF A PHARMACEUTICAL FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE, ANDROGRAPHOLIDE ENTERIC TARGETING MICROPELLET, AND METHOD FOR PREPARATION THEREOF
WO
12.02.2015
A61K 31/365 Loading...
A61K 31/365
Loading...
PCT/CN2014/083810
TASLY PHARMACEUTICAL GROUP CO., LTD.
SUN, Henry
A61K 31/365
Loading...
The present invention relates to an andrographolide enteric targeting micropellet and method for preparation thereof; furthermore, the present invention also relates to uses of andrographolide and andrographolide enteric targeting micropellets in the preparation of a pharmaceutical for treatment of inflammatory bowel disease.
61. 204147278 气冷滴丸生产线
CN
11.02.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
201420383833.6
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
一种气冷滴丸生产线，包括滴丸系统、气冷循环系统和控制系统，滴丸系统包括化料罐和与其相连的滴头，滴头下面设有振动装置，振动装置能够开关所述滴头，滴头上设有在线监测装置，该装置包括脉冲信号发射机构和对应设置的用于在线实时检测滴丸形状的检测机构，脉冲信号发射机构的发射频率与振动装置的振动频率相同，检测机构输出检测信号给控制系统，并根据所述检测信号控制调节滴制参数。本实用新型将振动滴制及在线监测控制、空气冷却与流化干燥包衣结合为一体，满足高速滴制、制备微丸以及提高载药量的要求，成倍提高滴丸载药量，大幅度降低辅料用量和服用剂量；完全无有机溶剂残留；满足包括缓释包衣、薄膜包衣和包糖衣在内的不同工艺要求。
62. 204147279 气冷滴丸生产线
CN
11.02.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
201420384495.8
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
一种气冷滴丸生产线，包括滴丸系统、气冷循环系统和控制系统，滴丸系统包括：化料罐和与其相连的滴头，化料罐与滴头之间设有振动装置，振动装置带动滴头上下振动，将滴头中流出的药液剪切成滴，落入气冷循环系统冷却后形成滴丸；气冷滴丸生产线还包括流化干燥包衣系统，该系统主要包括流化床，冷却管道的末端通过真空管道与流化床的入口相连，将经过气冷定型的滴丸素丸真空上料输入流化床内流化干燥包衣；流化床包括炉体，炉体下方设有物料进料口，在进料口的下方设有流化板，流化板的底部与常温低湿送风系统的出风管道相连通，常温低湿送风系统将常温低湿气体经过出风管道送入流化床炉体内，并对内置于炉体内部的物料进行流化干燥处理。
63. 204147280 气冷滴丸生产线
CN
11.02.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
201420387451.0
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
一种气冷滴丸生产线，包括滴丸系统、气冷循环系统和控制系统，滴丸系统包括化料罐和滴头，两者之间设有振动装置，振动装置带动滴头上、下振动，将滴头中流出的药液剪切成滴，落入气冷循环系统冷却后形成滴丸，滴头上设有在线监测装置，该装置包括脉冲信号发射机构，脉冲信号发射机构的发射频率与所述振动装置的振动频率相同，控制系统根据在线监测装置的监测结果，控制调节滴制参数。本实用新型将振动滴制及在线监测控制、空气冷却与流化干燥包衣结合为一体，满足高速滴制、制备微丸以及提高载药量的要求，成倍提高滴丸载药量，大幅度降低辅料用量和服用剂量；完全无有机溶剂残留；满足包括缓释包衣、薄膜包衣和包糖衣在内的不同工艺要求。
64. WO/2015/003660 AIR-COOLING DROP PILL PRODUCTION LINE
WO
15.01.2015
A61J 3/06 Loading...
A61J 3/06
Loading...
PCT/CN2014/082103
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61J 3/06
Loading...
An air-cooling drop pill production line comprises a drop pill system, an air-cooling circulation system, and a control system. The drop pill system comprises a molten material tank and a dripper; a vibration apparatus is arranged between the molten material tank and the dripper; the vibration apparatus drives the dripper to vibrate up and down. A vibration shear force cuts liquor flowing out from the dripper into drops, and after the drops fall into the air-cooling circulation system and are cooled, drop pills are formed. An online monitoring apparatus is arranged on the dripper, and the apparatus comprises a pulse signal emission mechanism; an emission frequency of the pulse signal emission mechanism is the same as a vibration frequency of the vibration apparatus. The control system controls a dropping parameter according to a monitoring result of the online monitoring apparatus. The vibration dropping, online monitoring and control, air cooling, and fluidized drying and coating are combined together, which satisfies the requirement of high-speed dropping and drop pill preparation and the requirement of improving a drug loading capacity, improves the drug loading capacity of drop pills exponentially, significantly reduces the usage of auxiliary materials and the dosage, completely avoids any residual organic solvent, and satisfies requirements of different processes including slow-release coating, film coating, and sugar coating.
65. WO/2015/003662 TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION AND APPLICATION THEREOF
WO
15.01.2015
A61K 36/537 Loading...
A61K 36/537
Loading...
PCT/CN2014/082105
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 36/537
Loading...
A traditional Chinese medicine composition and a preparation thereof, and in particular, a micro drop pill. The traditional Chinese medicine composition comprises 50.0% to 99.9% of salvia miltiorrhiza and Panax notoginseng extract and 0.1% to 50.0% of borneol (by weight percentage). The salvia miltiorrhiza and Panax notoginseng extract comprises the following components (by weight percentage): salvianic acid A: salvianolic acid T: protocatechuic aldehyde: salvianolic acid D: rosmarinic acid: salvianolic acid B: salvianolic acid A: Notoginsenoside R1: ginsenoside Rg1: ginsenoside Re: ginsenoside Rb1: ginsenoside Rd: dihydrotanshinoneI: tanshinone I: cryptotanshinone: tanshinone IIΑ = (2-5): (0.5-1.9): (1.1-3): (0.2-1.2): (0.2-1): (0.5-2): (0.5-2): (0.2-1): (1.5-4): (0.1-0.5): (1-3.9): (0.1-1): (0.01-0.05): (0.05-0.1): (0.02-0.1): (0.1-0.5). A preparation method for the micro drop pill comprises vibration dropping, air cooling, and the like. The method can be used to manufacture drop pills, coated drop pills, and drop pill capsules with a high drug loading capacity. The composition has an effect of treating acute myocardial ischemia and acute myocardial infarction.
66. WO/2015/003661 PREPARATION METHOD FOR TRADITIONAL CHINESE MEDICINE MICRO DROP PILL AND TRADITIONAL CHINESE MEDICINE MICRO DROP PILL PREPARED BY USING THE METHOD
WO
15.01.2015
A61K 9/20 Loading...
A61K 9/20
Loading...
PCT/CN2014/082104
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 9/20
Loading...
A preparation method for a traditional Chinese medicine micro drop pill and a traditional Chinese medicine micro drop pill prepared by using the method, and in particular, a micro drop pill preparation method that achieves a high drug loading capacity and has a simple preparation process and a high production rate, and a micro drop pill prepared by using the method. Specifically, the drop pill preparation method used comprises the following steps: (1) a material melting step: heating and melting medicine and a drop pill matrix to obtain a molten liquor; (2) a dropping step: delivering the molten liquor to a dripper, and acquiring drops of the molten liquor by means of vibration dropping; and (3) a condensation step: cooling the medicine drops with cooling air, to obtain micro drop pills.
67. WO/2015/003659 TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION AND APPLICATION THEREOF
WO
15.01.2015
A61K 36/537 Loading...
A61K 36/537
Loading...
PCT/CN2014/082102
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 36/537
Loading...
A traditional Chinese medicine composition for treating cardiovascular disease, and a preparation thereof, particularly a micro drop pill preparation thereof, and a method for preparing the preparation; the method for preparing the micro drop pill preparation can be used to prepare drop pills, coated drop pills, and drop pill capsules with a high drug loading capacity.
68. WO/2014/206310 USE OF CHINESE MEDICINE PREPARATION IN PREPARING DRUG FOR PREVENTING AND/OR TREATING CROHN'S DISEASE
WO
31.12.2014
A61K 36/898 Loading...
A61K 36/898
Loading...
PCT/CN2014/080812
TASLY PHARMACEUTICAL GROUP CO., LTD.
NIE, Zhaohong
A61K 36/898
Loading...
Use of Chinese medicine preparation in preparing a drug for preventing and/or treating Crohn's disease. The Chinese medicine preparation is made of 1% to 10% of dragon's blood by weight, 15% to 40% of red peony root by weight, 1% to 20% of natural indigo by weight, 1% to 10% of red halloysite by weight, 15% to 40% of catechu by weight, 1% to 10% of burnt alum by weight, 5% to 30% of Common Bletilla Tuber by weight, and 1% to 10% of calamina by weight.
69. 204033786 液冷滴丸生产线
CN
24.12.2014
A61J 3/06 Loading...
A61J 3/06
Loading...
201420383998.3
天士力制药集团股份有限公司
闫希军
A61J 3/06
Loading...
一种液冷滴丸生产线，包括滴丸系统、液冷循环系统和控制系统，滴丸系统包括化料罐和与其相连的滴头，化料罐与滴头之间设有振动装置，振动装置带动滴头上下振动，产生的振动剪切力，将滴头中流出的药液剪切成滴，落入液冷循环系统冷却后形成滴丸，滴头包括储料罐和设置在其底部的滴盘，滴盘上设有多个滴孔，滴孔的外围开设有凹形环槽。本实用新型通过滴孔的外围开设有凹形环槽，防止在黏稠液体高速喷出时，喷孔周围有残余的药液堆积，最终导致喷孔堵塞或影响滴制；结合高频切割滴制，在线实时检测并控制调节滴丸质量，提高产率。
70. 204035137 滴丸冷却装置的在线清洗设备
CN
24.12.2014
B08B 9/027 Loading...
B08B 9/027
Loading...
201420384401.7
天士力制药集团股份有限公司
闫希军
B08B 9/027
Loading...
一种滴丸冷却装置的在线清洗设备，包括：清洗单元、控制单元、升降驱动单元和升降单元，所述控制单元通过升降驱动单元驱动升降单元带动清洁单元升降，所述升降单元设置在冷却装置的冷却管道顶部外侧；所述升降单元包括：清洁单元支撑架、清洁管道、清洁管道支撑架、清洁管道收纳盘和密封接管；所述清洁管道支撑架使清洁管道延伸到冷却管道内部；所述清洁单元支架包括多个支撑轮，每一个所述支撑轮与冷却管道内侧壁抵顶，所述清洁单元与所述清洁管道延伸到冷却管道内部的一端连接，并通过清洁单元支撑架使清洁单元延冷却管道中心升降；所述密封接管的一端与清洁管道的另一端连接，用于将清洁液导入所述清洁管道内。
71. WO/2014/201994 SALVIA MILTIORRHIZA EXTRACT, MICROPELLET FORMULATION THEREOF, METHODS OF PREPARING SAME, AND USES THEREOF
WO
24.12.2014
A61K 36/537 Loading...
A61K 36/537
Loading...
PCT/CN2014/080077
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 36/537
Loading...
A salvia miltiorrhiza extract, a micropellet formulation thereof, methods of preparing same, and uses thereof are disclosed. The salvia miltiorrhiza extract contains the following component weight ratio: salvia miltiorrhiza elements : rosmarinic acid : lithospermic acid : salvianolic acid B : cryptotanshinone : tanshinone II A : stachyose = (0.5-16) : (0.5-15) : (0.5-15) : (5-140) : (0.5-25) :(1-50) : (150-600). The salvia miltiorrhiza extract of the present invention also contains a liposoluble active ingredient and a water-soluble active ingredient of salvia miltiorrhiza. The invention has excellent stability, contains low amounts of solvent residue, improves microcirculation, and reduces blood lipid levels.
72. 104215701 Method for determination of blood-nourishing and brain-clearing effective component
CN
17.12.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201310217700.1
天士力制药集团股份有限公司
王相阳
G01N 30/02
Loading...
The invention relates to a drug detection method, and in particular relates to a method for determination of a blood-nourishing and brain-clearing effective component. The method comprises the following steps: (1) sample treatment: taking a plasma sample, adding an acid solution and an internal standard solution, and carrying out vortex mixing; followed by adding an organic solvent, carrying out vortex mixing, and carrying out liquid-liquid extraction; and after the mixed liquid is centrifuged, taking the organic solvent layer, blow-drying, and then re-dissolving with a mobile phase, centrifuging, taking the supernatant, and injecting the sample for determination; and (2) determining by a liquid chromatograph-mass spectrometer.
73. 203975351 一种加装图像采集装置和集成收集装置的灌装机
CN
03.12.2014
B65B 57/04 Loading...
B65B 57/04
Loading...
201420336986.5
天士力制药集团股份有限公司
李常洪
B65B 57/04
Loading...
本实用新型提供一种加装图像采集装置和集成收集装置的灌装机，包括灌装机主体，包括落药口；计量盘，均布若干计量部；其中一计量部位于所述落药口正上方；计量盘上方安装有图像采集装置，用以向控制单元传输图像信息；还包括集成收集装置，包括收集传送带及剔除装置；所述控制单元存储有若干标准图片，用以比对前述图像信息，自动判断识别不合格药袋；并延时控制剔除装置剔除收集传动带上的不合格药袋。通过采用适合孔位法计量的计量盘，并加装图像采集装置及集成收集装置，能够实现布药过程中的自动化监测，并实现合格药袋和不合格药袋的独立收集。
74. 103969346 Panax notoginseng saponin component analysis method
CN
06.08.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201310030763.6
天士力制药集团股份有限公司
阚红玉
G01N 30/02
Loading...
The present invention provides a panax notoginseng saponin component analysis method, which comprises content determination and finger print determination of panax notoginseng saponin, and specifically comprises sample solution preparation, reference substance solution preparation, and determination of content and finger print of the panax notoginseng saponin component in compound danshen dripping pills by using ultra performance liquid chromatography. According to the present invention, the same chromatography conditions are adopted to concurrently determine the content and the finger print of the panax notoginseng saponin component, characteristics of good linearity, good repeatability, good stability and good recovery rate are provided, and the quality of the compound danshen dripping pills is easily and completely controlled.
75. 103926366 Detection method for effective components of astragalus Salvia Miltiorrhiza qi-benefiting dropping pill
CN
16.07.2014
G01N 30/90 Loading...
G01N 30/90
Loading...
201310014920.4
天士力制药集团股份有限公司
葛丹丹
G01N 30/90
Loading...
The invention provides a detection method for effective components of an astragalus Salvia Miltiorrhiza qi-benefiting dropping pill. The method includes identification of panax notoginseng, astragalus and Dalbergia odorifera and tanshinol content determination. Specifically, the method consists of: preparing a panax notoginseng and astragalus test solution, preparing a panax notoginseng and astragalus reference solution, conducting panax notoginseng and astragalus thin-layer identification, preparing a Dalbergia odorifera test solution, preparing a Dalbergia odorifera reference drug solution, performing Dalbergia odorifera thin-layer identification, and determining the tanshinol content by ultra-high performance liquid chromatography. Tests show that the method has very good linearity, repeatability, reproducibility and stability, as well as high recovery rate, and is conducive to more comprehensive control of the quality of the astragalus Salvia Miltiorrhiza qi-benefiting dropping pill.
76. WO/2014/094632 PHARMACEUTICAL COMPOSITION FOR TREATING HEADACHE, AND PREPARATION METHOD THEREOF
WO
26.06.2014
A61K 36/804 Loading...
A61K 36/804
Loading...
PCT/CN2013/089960
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 36/804
Loading...
A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.
77. 103675111 Method for detecting content of main component of nepal dock root in nephritis treatment tablets
CN
26.03.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201210327760.4
TASLY PHARMACEUTICAL GROUP CO., LTD.
ZHOU GUIRONG
G01N 30/02
Loading...
The invention discloses a method for detecting the content of a main component of nepal dock root in nephritis treatment tablets. According to the method, the contents of rheum emodin, chrysophanol and physcion in the nephritis treatment tablets by adopting a reversed-phase chromatography, wherein in the chromatographic condition, C18 columns are adopted, a mobile phase is a methyl-0.1% phosphoric acid solution, and the detecting wavelength is 210-320nm. The method is convenient to operate, high in sensitivity and good in reproducibility, and can provide a basis for the making of nephritis treatment tablet quality standards.
78. 103687850 一种取代桂皮酰胺衍生物、制备方法及其应用
CN
26.03.2014
C07D 317/64 Loading...
C07D 317/64
Loading...
201280020049.2
天士力制药集团股份有限公司
马晓慧
C07D 317/64
Loading...
本发明涉及一种取代桂皮酰胺衍生物、制备方法及其应用。本发明的取代桂皮酰胺衍生物具有式（I）结构，本发明还包括以取代胡椒醛衍生物为原料经过Wittig反应和酸胺缩合反应制备本发明的取代桂皮酰胺及其衍生物的方法以及可作为治疗和预防抑郁型精神疾病药物的应用。
79. 103623404 Haemophilus influenzac type B polysaccharide conjugate vaccine preparation method
CN
12.03.2014
A61K 39/385 Loading...
A61K 39/385
Loading...
201210311027.3
TASLY PHARMACEUTICAL GROUP CO., LTD.
LI JUNQIANG
A61K 39/385
Loading...
The present invention discloses a Haemophilus influenzac type B polysaccharide conjugate vaccine preparation method, which comprises: A, preparing a Haemophilus influenzac type B polysaccharide extract (PRP), adopting ultrapure water or water for injection to dissolve the PRP polysaccharide at a room temperature until achieving a concentration of 20 mg/ml, adding CDAP according to a mass ratio of PRP to CDAP of 1, maintaining for 1.5 min, adjusting the pH value to 9.5 with 0.3 M NaOH, maintaining for 3 min, adding a solid ADH according to a mass ratio of ADH to the PRP polysaccharide of 4:1, adjusting the pH value to 9.5 with 0.3 M NaOH, maintaining for 1 h, and carrying out dialysis at a temperature of 2-8 DEG C with 0.2 M NaCl; and B, mixing the obtained PRP-AH and a 20 mg/ml TT solution according to a mass ratio of 1:2, adjusting the pH value to 5.0 with 0.1 M HCL, adding a solid EDAC according to a mass ratio of EDAC to PRP of 10:1, maintaining the pH value of 5.0 for 60 min at a room temperature, adjusting the pH value to 7.5 with 0.3 M NaOH, and carrying out a reaction for 30 min.
80. 103630614 High performance liquid chromatography detection method of Yangxueqingnao granule
CN
12.03.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201210301559.9
天士力制药集团股份有限公司
陈晓鹏
G01N 30/02
Loading...
The invention provides a high performance liquid chromatography detection method of Yangxueqingnao granule. According to the high performance liquid chromatography detection method, Yangxueqingnao granule detection samples are extracted with methanol via ultrasonic extraction; high performance liquid chromatography-mass spectrum/mass spectrum is used for qualitative analysis of chemical components of an obtained extract; and high performance liquid chromatography is used for quantitative analysis of indexes or components of the extract. The high performance liquid chromatography detection method possesses excellent linearity, repeatability, reappearance and recovery rate, and is helpful for more comprehensive control of the quality of Yangxueqingnao granule.
81. 103627758 CRM197 protein production method
CN
12.03.2014
C12P 21/02 Loading...
C12P 21/02
Loading...
201210311131.2
TASLY PHARMACEUTICAL GROUP CO., LTD.
FAN BAOQING
C12P 21/02
Loading...
The present invention relates to a CRM197 protein production method, and belongs to the field of biomedical manufacturing. The process comprises: preparing a seed solution, carrying out CRM197 fermentation culture, centrifugating to remove bacterial, pre-treating the fermentation broth, carrying out Toyopearl DEAE-650S ion exchange to capture, adopting Butyl sepharose 4B to carry out hydrophobic purification, and carrying out ultra-filtration concentration liquid exchange (freeze-drying), wherein the protein purity after hydrophobic purification is not less than 95%. According to the present invention, the reasonable fermentation and purification process and the corresponding parameters are established, and process amplification and large-scale production can be easily achieved.
82. 103575816 Method for detecting leonurine hydrochloride content in nephritis elimination tablet
CN
12.02.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201210266259.1
天士力制药集团股份有限公司
周桂荣
G01N 30/02
Loading...
The invention discloses a method for detecting the leonurine hydrochloride content in a nephritis elimination tablet. The detection method adopts a reversed phase ion pair chromatography method to measure the leonurine hydrochloride content in a nephritis elimination tablet, wherein the chromatographic condition adopts a C18 column, the mobile phase is acetonitrile-0.1% phosphoric acid solution of 0.2-0.6% sodium 1-octanesulfonate, and the detection wavelength is 260 to 290 nm. The detection method has the advantages of convenient operation, high sensitivity, and good repeatability, and provides a reference for establishment of quality standards for the nephritis elimination tablet.
83. 103575823 Detection method of 8 chemical components in Tangminling preparation
CN
12.02.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201210281597.2
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
The invention provides a detection method of chemical components in a Tangminling preparation, which comprises the following steps: extracting a detected Tangminling preparation sample with methanol, and detecting by high performance liquid chromatography under the following chromatographic conditions: a C18 chromatographic column is adopted, the mobile phase A phase is methanol, the B phase is acetonitrile, and the C phase is a formic acid or acetic acid or phosphoric acid water solution, and the detector is a diode array detector. The method has favorable linearity, repetitiveness, reproducibility and recovery rate, and is beneficial to more comprehensively controlling the quality of the Tangminling.
84. 103575820 Analysis method for five flavonoid glycosides in blood plasma and application of five flavonoid glycosides in pharmacokinetics
CN
12.02.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201210272757.7
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
The invention provides a method for quantitatively detecting naringin, aurantiamarin, neohesperidin, baicalin and wogonoside in a blood plasma sample by adopting liquid chromatography tandem mass spectrometry, and the method comprises the following steps: (1) preparaing a sample; (2) detecting. The analysis method provided by the invention has good specificity, high precision degree, high accuracy and wide linear range and can be used for in vivo pharmacokinetic determination of Chinese medicinal compositions.
85. 103575842 肾炎清片中黄芪主要成分检测方法
CN
12.02.2014
G01N 30/88 Loading...
G01N 30/88
Loading...
201210257780.9
天士力制药集团股份有限公司
周桂荣
G01N 30/88
Loading...
本发明涉及中药肾炎清片中黄芪主要成分检测方法，该方法包括以下步骤：步骤1，对照品溶液的制备，步骤2，供试品溶液的制备，步骤3，将对照品溶液和供试品溶液注入色谱仪，得到色谱图，步骤4，根据色谱图用外标两点法对数方程计算供试品中黄芪甲苷的含量。
86. 103575830 Analysis method for four anthraquinones in blood plasma and application of four anthraquinones in pharmacokinetics
CN
12.02.2014
G01N 30/06 Loading...
G01N 30/06
Loading...
201210272432.9
天士力制药集团股份有限公司
佟玲
G01N 30/06
Loading...
The invention discloses an analysis method for determining rheum emodin, aloe-emodin, chrysophanol and emodin monomethyl ether in blood plasma at the same time and application of rheum emodin, aloe-emodin, chrysophanol and emodin monomethyl ether in pharmacokinetics, wherein the analysis method for determining rheum emodin, aloe-emodin, chrysophanol and emodin monomethyl ether in the blood plasma at the same time comprises the following steps: (1) preparing a sample; (2) detecting. The analysis method for determining rheum emodin, aloe-emodin, chrysophanol and emodin monomethyl ether in the blood plasma at the same time has good specificity, high precision degree, high accuracy and wide linear range and can be used for in vivo pharmacokinetic determination of Chinese medicinal compositions.
87. 103389353 Ultra-high performance liquid chromatography method for determination of content of phenolic acid components in blood-nourishing cephalocathartic particles
CN
13.11.2013
G01N 30/88 Loading...
G01N 30/88
Loading...
201210138333.1
天士力制药集团股份有限公司
佟玲
G01N 30/88
Loading...
The invention relates to an ultra-high performance liquid chromatography method for determination of contents of four phenolic acid components in blood-nourishing cephalocathartic particles. The method comprises the following steps: 1, preparation of a contrast sample solution; 2, preparation of a tested object solution of a blood-nourishing cephalocathartic particle preparation; 3, injection of the contrast sample solution and the tested object solution into a ultra-high performance liquid chromatograph to obtain a chromatogram; and 4, calculating the contents of four phenolic acid components in the tested object solution according to the chromatogram.
88. 103293232 一种藿香正气滴丸中百秋李醇含量的测定方法
CN
11.09.2013
G01N 30/02 Loading...
G01N 30/02
Loading...
201210044437.6
天士力制药集团股份有限公司
阚红玉
G01N 30/02
Loading...
一种藿香正气滴丸中百秋李醇含量的测定方法，该方法包括如下步骤：步骤1，对照品溶液的制备；步骤2，供试品溶液的制备；步骤3，阴性样品溶液的制备；步骤4，注入气相色谱仪，计算百秋李醇含量。
89. 103285143 养血清脑颗粒对脑血管周围水肿的预防作用
CN
11.09.2013
A61K 36/804 Loading...
A61K 36/804
Loading...
201310143736.X
天士力制药集团股份有限公司
韩晶岩
A61K 36/804
Loading...
本发明涉及一种中药制剂的新用途，特别涉及中药养血清脑颗粒对预防脑血管周围水肿的应用，本发明实验数据表明，养血清脑颗粒对大脑中动脉缺血再灌注后脑血管周围水肿具有预防作用。
90. 103242284 一种钯催化的5-三氟甲基胡椒醛的合成方法
CN
14.08.2013
C07D 317/54 Loading...
C07D 317/54
Loading...
201210022390.3
天士力制药集团股份有限公司
韩民
C07D 317/54
Loading...
本发明涉及一种钯催化的5-三氟甲基胡椒醛的合成方法，该方法包括，在氮气保护下，以N，N-二甲基甲酰胺为溶剂，1.0当量的5-碘胡椒醛，5.0-10.0当量的FSO2CF2COOCH3，2.5-5.0当量的卤化亚铜盐，0.1-0.2当量的钯催化剂加热至100℃反应8-16小时；反应液经硅藻土过滤，滤液蒸干后经柱层析分离，洗脱液为体积比10∶1的石油醚和乙酸乙酯的混合液，得白色固体即5-三氟甲基胡椒醛。
91. 103245733 一种藿香正气滴丸鉴定方法
CN
14.08.2013
G01N 30/02 Loading...
G01N 30/02
Loading...
201210024320.1
天士力制药集团股份有限公司
阚红玉
G01N 30/02
Loading...
本发明涉及一种藿香正气滴丸鉴定方法，其特征在于，该方法包括以下步骤：步骤1、标准藿香正气滴丸指纹图谱的制备；步骤2、待测藿香正气滴丸指纹图谱的制备；步骤3、对指纹图谱的相似性进行比较，两者相似表明待测藿香正气滴丸合格。
92. WO/2013/102437 USES OF DANSHEN OR DANSHEN PREPARATION IN PREPARATION OF DRUGS FOR TREATING DISEASES RELATED TO HEPATIC FIBROSIS
WO
11.07.2013
A61K 36/537 Loading...
A61K 36/537
Loading...
PCT/CN2013/070037
TASLY PHARMACEUTICAL GROUP CO., LTD.
ZHU, Yonghong
A61K 36/537
Loading...
Disclosed are uses of Danshen or Danshen preparation in preparation of drugs for treating diseases related to hepatic fibrosis.
93. 103197003 一种柴胡药材的鉴定方法
CN
10.07.2013
G01N 30/02 Loading...
G01N 30/02
Loading...
201210000715.8
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
本发明涉及一种柴胡药材的鉴定方法，该方法包括以下步骤：步骤1、对照品溶液的制备；步骤2、供试品溶液的制备；步骤3、将步骤1和步骤2所述的溶液分别注入HPLC色谱仪中，得到色谱图；步骤4、对色谱图的相似性进行比较，两者相似表明供试品合格。
94. 103197002 一种聚乙二醇4000中环氧乙烷和二氧六环的残留物含量的检测方法
CN
10.07.2013
G01N 30/02 Loading...
G01N 30/02
Loading...
201210000713.9
天士力制药集团股份有限公司
佟玲
G01N 30/02
Loading...
本发明涉及一种聚合物中的杂质检测方法，特别涉及一种聚乙二醇4000中环氧乙烷和二氧六环的残留物含量的检测方法。
95. 103197018 一种养血清脑颗粒蒽醌类成分检测方法
CN
10.07.2013
G01N 30/88 Loading...
G01N 30/88
Loading...
201210000960.9
天士力制药集团股份有限公司
靳元鹏
G01N 30/88
Loading...
本发明涉及一种养血清脑颗粒蒽醌类成分检测方法，包括以下步骤：步骤1，对照品溶液的制备；步骤2，供试品溶液的制备；步骤3，注入色谱仪，得到色谱图；步骤4，根据色谱图得到供试品溶液中蒽醌类成分的种类。
96. 103191186 丹参制剂在制备抗肝纤维化药物中的应用
CN
10.07.2013
A61K 36/537 Loading...
A61K 36/537
Loading...
201210000557.6
天士力制药集团股份有限公司
朱永宏
A61K 36/537
Loading...
本发明属于医药领域，具体涉及丹参或丹参制剂在制备抗肝纤维化药物中的应用。
97. 103110605 一种热熔胶囊制剂及其制备方法
CN
22.05.2013
A61K 9/48 Loading...
A61K 9/48
Loading...
201110364638.X
天士力制药集团股份有限公司
杨建会
A61K 9/48
Loading...
本发明公开了一种热熔胶囊制剂及其制备方法，其组成为：硬胶囊壳，含有中药成分和低熔点辅料，其中，中药成分和低熔点辅料是在熔融状态下装入硬胶囊壳的，本发明通过对熔融物装胶囊温度、熔融物装囊时水分的控制；得到一种装载量大的热熔胶囊制剂。
98. 103091388 一种中药产品重金属含量的检测方法
CN
08.05.2013
G01N 27/62 Loading...
G01N 27/62
Loading...
201110343089.8
天士力制药集团股份有限公司
孙巍
G01N 27/62
Loading...
本发明涉及一种中药产品重金属含量的检测方法，该方法包括以下步骤：步骤1，标准溶液的制备；步骤2，内标溶液的制备；步骤3，供试中药产品溶液的制备；步骤4，将制备的标准品溶液，内标溶液以及供试中药产品溶液注入质谱仪，测定其图谱，用标准曲线法计算供试中药产品中18种重金属的含量。
99. 103091454 复方丹参滴丸生产过程的总有机碳检测方法
CN
08.05.2013
G01N 33/00 Loading...
G01N 33/00
Loading...
201110333099.3
天士力制药集团股份有限公司
王建平
G01N 33/00
Loading...
本发明涉及一种复方丹参滴丸生产过程的总有机碳检测方法，该方法步骤如下：步骤1，取样；步骤2，样品处理；步骤3，样品检测。其中，步骤1中取样为擦拭取样或淋洗水取样；其中，步骤2所述样品处理，方法如下：擦拭样品：用移液枪精密移取40ml超纯水至装有擦拭样品的TOC小瓶中，振摇1min使棉签上的物质充分溶解，样品溶解后溶液无色，待检，淋洗水：振摇盛有淋洗水的TOC样品瓶1min，样品应无色，待检；其中，步骤3所述样品检测，方法如下：检测前，将样品再次振摇，使溶液混匀，将样品瓶放入TOC测定仪进行检测，计算TOC值。
100. 103068398 丹参组合物在制备用于冠心病二级预防的药物中的用途
CN
24.04.2013
A61K 36/53 Loading...
A61K 36/53
Loading...
201180036131.X
天士力制药集团股份有限公司
闫希军
A61K 36/53
Loading...
提供了丹参组合物在制备冠心病二级预防的药物中的应用，特别是提供了丹参组合物在制备稳定型心绞痛型冠心病二级预防和减少严重血管事件的药物中的应用。
101. 103063789 同时检测大叶蒟中12个酰胺类生物碱的液相分析方法
CN
24.04.2013
G01N 30/88 Loading...
G01N 30/88
Loading...
201110318120.2
天士力制药集团股份有限公司
罗学军
G01N 30/88
Loading...
本发明提供一种同时检测大叶蒟中12个酰胺类生物碱的液相分析方法，该方法包括以下步骤：步骤1，12个化合物对照品溶液的制备；步骤2，检测样品溶液的制备；步骤3，含量测定：分别精密吸取对照品溶液与供试品溶液，注入液相色谱仪，测定；该方法能够很好的分离12个生物碱并且有效避免了其他杂质的干扰，方法简单、快速、专属性强，稳定性好，可以用于大叶蒟药材及相关产品的质量控制。
102. 103059149 一种PRP核糖提取方法
CN
24.04.2013
C08B 37/00 Loading...
C08B 37/00
Loading...
201110318119.X
天士力制药集团股份有限公司
李军强
C08B 37/00
Loading...
本发明涉及B型流感嗜血杆菌聚核糖基核糖醇磷酸酯纯化方法，该方法包括以下步骤：(1)从B型流感嗜血杆菌发酵液中去除菌体得到发酵液上清；(2)从发酵液上清中去除核酸和蛋白，得到PRP多糖。
103. 103027904 咖啡酸用于制备抑制白细胞Src的活化的药物中的应用
CN
10.04.2013
A61K 31/192 Loading...
A61K 31/192
Loading...
201110227981.X
天士力制药集团股份有限公司
韩晶岩
A61K 31/192
Loading...
本发明揭示了咖啡酸可以抑制高同型半胱氨酸诱导的白细胞非受体酪氨酸激酶Src的活化，进而，抑制了PI3K/Akt信号通路，抑制了白细胞粘附分子整合素β2的表达，抑制了高同型半胱氨酸血症诱导的小鼠软脑膜细静脉白细胞的滚动和粘附，因此可以得出咖啡酸对于高同型半胱氨酸血症引发的脑血管病变性疾病有防治作用。
104. 102958510 一种水飞蓟宾药物组合包装物及其制备方法
CN
06.03.2013
A61K 9/08 Loading...
A61K 9/08
Loading...
201180029030.X
天士力制药集团股份有限公司
陈建明
A61K 9/08
Loading...
一种水飞蓟宾药物组合包装物及其制备方法。该药物组合包装物包括水飞蓟宾注射溶液和注射溶媒，两者分别装载在各自的容器中，组合包装在一起。所述水飞蓟宾注射溶液包含活性成分、磷脂和注射或溶剂A。所述注射溶媒包含胆盐和注射溶剂B。
105. 102885922 Preparation method of slimming drug
CN
23.01.2013
A61K 36/752 Loading...
A61K 36/752
Loading...
201110200790.4
天士力制药集团股份有限公司
周水平
A61K 36/752
Loading...
The invention relates to a preparation method of a slimming drug which is prepared from the following Chinese medicine raw materials: raw rhubarb, ginger-processed coptis, raw hawthorn, fermentum rubrum, pummelo peel, lightyellow sophora root, rhizoma atractylodis, semen descurainiae, plantain seed and cassia seed. The preparation method comprises steps of decocting with water, and precipitating with alcohol.
106. 102885921 Slimming Chinese medicine composition
CN
23.01.2013
A61K 36/752 Loading...
A61K 36/752
Loading...
201110200789.1
天士力制药集团股份有限公司
周水平
A61K 36/752
Loading...
The invention relates to a slimming Chinese medicine composition which is prepared from the following Chinese medicine raw materials: raw rhubarb, ginger-processed coptis, raw hawthorn, fermentum rubrum, pummelo peel, lightyellow sophora root, rhizoma atractylodis, semen descurainiae, plantain seed and cassia seed.
107. 102885923 Preparation method of slimming drug
CN
23.01.2013
A61K 36/752 Loading...
A61K 36/752
Loading...
201110200846.6
天士力制药集团股份有限公司
仝小林
A61K 36/752
Loading...
The invention relates to a preparation method of a slimming drug which is prepared from the following Chinese medicine raw materials: raw rhubarb, ginger-processed coptis, raw hawthorn, fermentum rubrum, pummelo peel, lightyellow sophora root, rhizoma atractylodis, semen descurainiae, plantain seed and cassia seed. The preparation method comprises a step of decocting with water.
108. 102885920 Slimming Chinese medicine preparation composition
CN
23.01.2013
A61K 36/752 Loading...
A61K 36/752
Loading...
201110200780.0
天士力制药集团股份有限公司
仝小林
A61K 36/752
Loading...
The invention relates to a slimming Chinese medicine preparation composition which is prepared from the following Chinese medicine raw materials: raw rhubarb, ginger-processed coptis, raw hawthorn, fermentum rubrum, pummelo peel, lightyellow sophora root, rhizoma atractylodis, semen descurainiae, plantain seed and cassia seed.
109. 102885919 Preparation of slimming drug
CN
23.01.2013
A61K 36/752 Loading...
A61K 36/752
Loading...
201110200779.8
天士力制药集团股份有限公司
张兰兰
A61K 36/752
Loading...
The invention relates to preparation of a slimming drug which is prepared from the following Chinese medicine raw materials: raw rhubarb, ginger-processed coptis, raw hawthorn, fermentum rubrum, pummelo peel, lightyellow sophora root, rhizoma atractylodis, semen descurainiae, plantain seed and cassia seed. The preparation method comprises steps of decocting with water, precipitating with alcohol and using the precipitate as pharmaceutically active substances to process the medicinal preparation.
110. WO/2013/000399 SUBSTITUTED CINNAMAMIDE DERIVATIVE, PREPARATION METHOD AND USE THEREOF
WO
03.01.2013
C07D 317/64 Loading...
C07D 317/64
Loading...
PCT/CN2012/077549
TASLY PHARMACEUTICAL GROUP CO., LTD.
MA, Xiaohui
C07D 317/64
Loading...
The present invention relates to a substituted cinnamamide derivative, a preparation method and the use thereof. The substituted cinnamamide derivative of the present invention has a structure as represented by formula (I). Also disclosed are a method for preparing the substituted cinnamamide of the present invention and the derivatives thereof by using the substituted piperonal derivatives as raw materials via a Wittig reaction and an acid-amine condensation reaction, and the use thereof as a medicament for the treatment and prevention of depressive psychoses.
111. 102850317 Substituted cinnamide derivative, its preparation method and application
CN
02.01.2013
C07D 317/50 Loading...
C07D 317/50
Loading...
201210123842.7
天士力制药集团股份有限公司
马晓慧
C07D 317/50
Loading...
The invention relates to a substituted cinnamide derivative of formula (i), its preparation method and application. The invention further discloses a method for preparing substituted cinnamide and its derivative by using a substituted heliotropin derivative as a raw material and conducting Wittig reaction and acid amine condensation, and an application of substituted cinnamide and its derivative in medicines for treating and preventing depressive psychosis.
112. 102826265 Manipulator unit and production line with same
CN
19.12.2012
B65B 61/24 Loading...
B65B 61/24
Loading...
201110161075.4
天士力制药集团股份有限公司
李国华
B65B 61/24
Loading...
The invention provides a manipulator unit which comprises a machine frame, a power source and a control device, wherein the power source and the control device are connected, and the power source is controlled via the control device; a clamp plate device is arranged on the machine frame, and comprises a fixing plate on which a supporting rod is arranged; the supporting rod is hinged with a clamp plate arm; the clamp plate arm comprises an upper clamp plate arm and a lower clamp plate arm; an opening groove is arranged at the upper clamp plate arm, and a clamp plate is arranged at the tail end of the lower clamp plate arm; one end of a shifting fork is arranged in the opening groove of the upper clamp plate groove in a manner of slipping, and while the other end of the shifting fork is connected with a first power source and driven by the first power source to move in a vertical direction by a reciprocating way; the fixing plate is connected with a second power source, and the clamp plate drive is driven to upwards move in the level direction by the reciprocating way through the fixing plate; and a working channel is also arranged on the machine frame. A production line is structured as follows: the manipulator units are arranged at intervals in a conveyor belt; and a baffle plate is arranged between the working channels of two adjacent manipulator units. The manipulator unit and the production line have simple structures, can be operated conveniently, and have accurate working positions; the products are shaped during being picked; and with adoption of the manipulator unit and the production line, the continuous production can be achieved along with high production efficiency and high controllability can be ensured.
113. 102775394 一种酰胺类化合物及其制备方法和应用
CN
14.11.2012
C07D 405/06 Loading...
C07D 405/06
Loading...
201110123076.X
天士力制药集团股份有限公司
靳元鹏
C07D 405/06
Loading...
本发明涉及一种酰胺类化合物及其制备方法和应用，具体而言，本发明涉及具有式(I)结构的化合物、它们的制备方法和含有它们的药物组合，以及在制备治疗和预防精神疾病药物中的应用，其中，(C2-C3)n至少含有一个碳碳单键和一个碳碳双键，且n为8。
114. 102702358 针对CSF-1R的抗体
CN
03.10.2012
C07K 16/28 Loading...
C07K 16/28
Loading...
201210195491.0
天士力创世杰（天津）生物制药有限公司
H·埃热尔
C07K 16/28
Loading...
本发明提供对CSF-1R特异的抗体、包含所述抗体的组合物和使用此类组合物的治疗方法。
115. 102688361 Traditional Chinese medicinal composition for treating dysmenorrhoea and preparation thereof
CN
26.09.2012
A61K 36/8905 Loading...
A61K 36/8905
Loading...
201110067265.X
天士力制药集团股份有限公司
周桂荣
A61K 36/8905
Loading...
The invention relates to a traditional Chinese medicinal composition, especially to a traditional Chinese medicinal composition for treating dysmenorrhoea and a preparation thereof. The formula of the composition comprises the following traditional Chinese medicinal raw medicines: 3-6 kg of tarragon, 6-12 kg of Cyperus Rotundus L with vinegar, 3-6 kg of evodia, 3-6 kg of Ligusticum wallichii, 0.5-1.0 kg of cassia twig, 100-400 g of borneol and 1.5-4.5 g of capsicine.
116. 102670404 Dropping pill deoiling dryer
CN
19.09.2012
A61J 3/06 Loading...
A61J 3/06
Loading...
201110058397.6
天士力制药集团股份有限公司
李常洪
A61J 3/06
Loading...
A dropping pill deoiling dryer comprises a support (1) and a rotating drum (2) which is fixed on the support (1). The rotating drum (2) rotates through driving of a first electrical motor, a feeding and discharging port (21) is arranged on the rotating drum, an adhesive medium is laid on the inner wall of the rotating drum (2), a liquid collecting device is arranged inside the rotating drum (2), the liquid collecting device comprises a first scraping knife (3), a cutting edge of the first scraping knife (3) is in contact with the surface of the adhesive medium arranged on the inner wall of the rotating drum (2), the first scraping knife (3) is connected with a first collecting pipe, a runner (5) is arranged inside the rotating drum (2) , a second electrical motor drives the runner (5) to rotate, the outer surface of the runner (5) and the inner wall of the rotating drum (2) are arranged at intervals, and the interval ranges between 20 mm and 80 mm. The dropping pill deoiling dryer is simple in structure, convenient to operate, disassemble and assemble, high in controllability and capable of removing liquid residues on surfaces of dropping pills by the adhesive effect of the medium and achieving continuous production.
117. 102579842 Traditional Chinese medicinal composition for treating tourette syndrome and preparation method of traditional Chinese medicinal composition
CN
18.07.2012
A61K 36/8988 Loading...
A61K 36/8988
Loading...
201110003966.7
天士力制药集团股份有限公司
朱永宏
A61K 36/8988
Loading...
The invention relates to a traditional Chinese medicinal composition for treating tourette syndrome. The traditional Chinese medicinal composition is prepared from the following raw materials in parts by weight: 242.5-970 parts of white paeony root, 177.5-710 parts of gastrodia tuer, 208-832 parts of caltrop, 218-872 parts of uncaria, 162.5-650 parts of lucid ganoderma, 155-620 parts of vine of multiflower knotweed, 155-620 parts of vine of spina date seed, 155-620 parts of schisandra chinensis, 155-620 parts of cape jasmine, 143.5-574 parts of bile arisaema and 107.5-430 parts of scutellaria baicalensis.
118. WO/2012/079419 PHARMACEUTICAL COMPOSITION FOR TREATING MACULAR DEGENERATION
WO
21.06.2012
A61K 36/9066 Loading...
A61K 36/9066
Loading...
PCT/CN2011/080758
TASLY PHARMACEUTICAL GROUP CO., LTD.
JIN, Ming
A61K 36/9066
Loading...
A pharmaceutical composition for treating macular degeneration is consisting of Astragalus membranaceus (Fisch.) Bunge, Angelica sinensis, Poria cocos (Schw.) Wolf, Fritillaria thunbergii Miq., Panax pseudo-ginseng var. notoginseng, charred Radix et Rhizoma Rhei, Pollen Typhae, and Curcuma aromatica Salisb. The pharmaceutical composition is added with conventional adjuvants, and prepared, following a conventional process, into various pharmaceutically acceptable dosage forms including decoction, tablet, capsule, bolus, oral liquid preparation, and injection. The pharmaceutical composition can enhance and stabilize the vision of an AMD patient, promote absorption of hemorrhage, reduce macular area CNV fluorescein leakage, have a desired inhibition effect on CNV of BN rats induced by laser, and have a certain effect in inhibiting or stabilizing the growth of choroidal neovascularization membrane.
119. WO/2012/068962 USE OF COMPOUND SALVIA MILTIORRHIZA PREPARATION IN PREPARING MEDICAMENT FOR RESISTING PULMONARY HYPERTENSION
WO
31.05.2012
A61K 36/53 Loading...
A61K 36/53
Loading...
PCT/CN2011/082145
TASLY PHARMACEUTICAL GROUP CO., LTD.
ZHU, Yonghong
A61K 36/53
Loading...
Disclosed are uses of a preparation made from salvia miltiorrhiza, panax pseudo-ginseng and borneol in preparing medicaments for resisting pulmonary hypertension, pulmonary heart disease, emphysema or congestive heart failure.
120. 102478551 一种测定土荆芥挥发油中有效成分含量的方法
CN
30.05.2012
G01N 30/02 Loading...
G01N 30/02
Loading...
201010555963.X
天津天士力制药股份有限公司
张兰兰
G01N 30/02
Loading...
本发明涉及一种测定土荆芥挥发油中有效成分含量的方法，所述方法包括以下步骤：步骤1，土荆芥挥发油溶液的配制；步骤2，注入高效液相色谱仪测定峰面积；步骤3，计算土荆芥挥发油中有效成分含量。
121. 102478553 一种水飞蓟宾的检测方法
CN
30.05.2012
G01N 30/02 Loading...
G01N 30/02
Loading...
201010556030.2
天津天士力制药股份有限公司
褚扬
G01N 30/02
Loading...
本发明属于医药领域，具体涉及一种水飞蓟宾的检测方法，本发明的方法，包括以下步骤：步骤1、含有水飞蓟宾A与水飞蓟宾B的血浆经沉淀蛋白预处理；步骤2、将经过预处理的血浆，经液-质联用仪，测定其中水飞蓟宾A与水飞蓟宾B浓度。
122. 102475779 一种治疗原发性高血压的中药组合物的制备方法
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010564323.5
天士力制药集团股份有限公司
周水平
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压的中药组合物的制备方法，所述组合物制备方法包括以下步骤：酒大黄、决明子、姜黄连、茺蔚子和钩藤加乙醇加热至沸腾后，提取，过滤，药渣加乙醇加热至沸腾后，提取，过滤，药渣弃去，将两次提取液合并，得到上清液1。夏枯草、地龙和红曲加水浸泡，加热至沸腾后，提取，过滤，药渣加水煎煮，过滤，药渣弃去，将次提取液合并，浓缩，得浓缩液，冷却至室温后，加乙醇醇沉，边加边搅拌，静置，滤过，沉淀弃去，得到上清液2。将上清液1和上清液2混合均匀减压浓缩至干。
123. 102475785 一种治疗原发性高血压的中药组合物的制备方法1
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010566577.0
天津天士力制药股份有限公司
周水平
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压的中药组合物的制备方法，其特征在于，所述组合物由以下重量份的原料药经过加工制成：大黄3-12份；姜黄连7.5-30份；决明子15-60份钩藤15-60份；茺蔚子15-60份；夏枯草22.5-90份；地龙15-60份 红曲3-12份。所述制备方法包括以下步骤：全方加5～10倍60～95％乙醇浸泡0.5～1h，加热至沸腾后，提取1～3h，过滤，药渣加5～10倍60～95％乙醇提取1～3h，过滤，药渣弃去，将两次提取液合并，55～65℃减压浓缩至流浸膏或干粉，以上工艺得到的活性物质与药物可接受的载体混合，按照制剂学常规技术制成。
124. 102475782 一种治疗原发性高血压的中药组合物的制备方法
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010564436.5
天津天士力制药股份有限公司
仝小林
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压的中药组合物的制备方法，所述组合物的制备方法包括以下步骤：除钩藤外，其余药材加水浸泡，加热至沸腾后，提取，过滤，药渣中加入钩藤，加水煎煮，过滤，药渣弃去，将两次提取液合并，浓缩至流浸膏或干粉。
125. 102475778 一种治疗原发性高血压的中药组合物的制备方法5
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010564295.7
天津天士力制药股份有限公司
张兰兰
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压的中药组合物的制备方法，所述组合物制备方法包括以下步骤：酒大黄、姜黄连加乙醇浸泡，加热至沸腾后，提取，过滤，药渣加乙醇煎煮，过滤，药渣弃去，将两次提取液合并，得到提取液1。钩藤、夏枯草、决明子加水浸泡，加热至沸腾后，提取，过滤，药渣加水煎煮h，过滤，药渣弃去，将两次提取液合并，得到提取液2。茺蔚子、地龙、红曲加水浸泡，加热至沸腾后，提取，过滤，药渣加水煎煮，过滤，药渣弃去，将两次提取液合并，浓缩，得浓缩液，冷却，加乙醇醇沉，边加边搅拌，静置，滤过，沉淀弃去，滤液浓缩，得到提取液3。将提取液1、提取液2和提取液3混合均匀，浓缩至流浸膏或干粉。
126. 102475698 丹酚酸L在制备治疗肿瘤药物中的应用
CN
30.05.2012
A61K 31/216 Loading...
A61K 31/216
Loading...
201010566647.2
天士力制药集团股份有限公司
周水平
A61K 31/216
Loading...
本发明涉及丹酚酸L在制备治疗肿瘤药物中的应用，丹酚酸L属于酚酸类化合物是从中药丹参提取得到的并确认结构的水溶性新化合物，药理研究表明具有抗氧化作用和抗心肌缺血作用，本专利公开了丹酚酸L诱导肿瘤细胞凋亡，对肿瘤细胞有杀伤作用，动物实验显示，丹酚酸L具有一定抗肿瘤活性且未体现出毒性，可显著增强各种肿瘤药物5-氟尿嘧啶、丝裂霉素C等抗肿瘤活性，该化合物有望应用于临床肿瘤治疗。
127. 102475746 大叶蒟有效组分的制备方法
CN
30.05.2012
A61K 36/67 Loading...
A61K 36/67
Loading...
201010556017.7
天士力制药集团股份有限公司
靳元鹏
A61K 36/67
Loading...
本发明涉及中药的提取技术，特别涉及一种大叶蒟有效组分的制备方法，该有效组分用以下方法制备：步骤1，大叶蒟用乙醇提取，得到醇提物；步骤2，醇提物过大孔树脂柱，乙醇为冲洗液；弃掉前两次冲洗液，步骤3，收集第三批洗脱液，浓缩得到本发明有效组分提取物，本发明大叶蒟提取物在制备治疗抑郁症和焦虑症等精神疾病的药物中有很好的应用前景。
128. 102475742 灭活罂粟籽榨油后残渣及其提取物作为制备镇痛药物的应用
CN
30.05.2012
A61K 36/66 Loading...
A61K 36/66
Loading...
201010555990.7
天士力制药集团股份有限公司
周水平
A61K 36/66
Loading...
本发明涉及罂粟籽榨油后残渣及其提取物作为制备镇痛药物的应用，本发明发现，罂粟籽榨油后残渣含有药物成分，可以用于制备药物，本发明还发现，罂粟籽榨油后残渣经过提取可以得到药物提取物，该提取物可以用于制备药物，本发明所述的药物，是用上述罂粟籽榨油后残渣或其提取物作为药物活性成分制备成的药物组合物。
129. 102475781 一种治疗原发性高血压的中药组合物的制备方法3
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010564325.4
天津天士力制药股份有限公司
周水平
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压的中药组合物的制备方法，所述组合物由以下重量份的原料药经过加工制成：酒大黄3-12份，姜黄连7.5-30份，决明子15-60份，钩藤15-60份，茺蔚子15-60份，夏枯草22.5-90份，地龙15-60份，红曲3-12份。
130. 102475780 一种治疗原发性高血压的中药组合物的制备方法6
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010564324.X
天津天士力制药股份有限公司
周水平
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压中药组合物的制备方法，所述组合物由以下制备方法制成：酒大黄、姜黄连加水浸泡，加热至沸腾后，提取，过滤，药渣加水提取，过滤，药渣弃去，将两次提取液合并，得到提取液1。钩藤、决明子、茺蔚子加乙醇浸泡，加热至沸腾后，提取，过滤，药渣加乙醇提取，过滤，药渣弃去，将两次提取液合并，得到提取液2。夏枯草、地龙、红曲加水浸泡，加热至沸腾后，提取，过滤，药渣加水煎煮，过滤，药渣弃去，将两次提取液合并，减压浓缩得浓缩液，冷却至室温后，加醇醇沉，静置，滤过，沉淀弃去，滤液浓缩，得到提取液3。将提取液1、提取液2和提取液3混合，浓缩至流浸膏或干粉。
131. 102475784 一种治疗原发性高血压的中药组合物及其制备方法
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010566510.7
天士力制药集团股份有限公司
仝小林
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压的中药组合物及其制备方法，其特征在于，所述组合物由以下重量份的原料药经过加工制成：酒大黄3-12份 姜黄连7.5-30份 决明子15-60份钩藤15-60份 茺蔚子15-60份 夏枯草22.5-90份地龙15-60份 红曲3-12份。
132. 102475736 黄芪提取物的应用
CN
30.05.2012
A61K 36/481 Loading...
A61K 36/481
Loading...
201010566580.2
天津天士力制药股份有限公司
程翼宇
A61K 36/481
Loading...
本发明属于药学领域，涉及黄芪提取物在保护缺血心肌，改善心功能方面的应用。本发明所述的黄芪提取物通过促进缺血区的血管生成，从而保护缺血心肌，改善心功能。
133. 102475783 一种治疗原发性高血压的中药组合物的制备方法
CN
30.05.2012
A61K 36/74 Loading...
A61K 36/74
Loading...
201010566508.X
天士力制药集团股份有限公司
张兰兰
A61K 36/74
Loading...
本发明涉及一种治疗原发性高血压的中药组合物的制备方法，所述组合物制备方法包括以下步骤：酒大黄加乙醇提取，过滤，药渣加乙醇提取，过滤，药渣弃去，合并提取液，浓缩，加水稀释，离心取上清液，纯化，上样，水洗，乙醇洗脱，洗脱液浓缩至干。姜黄连加乙醇提取，过滤，药渣加乙醇提取，过滤，药渣弃去，合并提取液，浓缩，冷却至室温后，加盐酸调节pH，过滤，滤液弃去，取沉淀部分干燥即得。除酒大黄与姜黄连外其余药味，加水浸泡，加热至沸腾后，提取，过滤，药渣加水煎煮，过滤，药渣弃去，将提取液合并，浓缩，得浓缩液，冷却至室温后，加乙醇醇沉，边加边搅拌，静置，滤过，沉淀弃去，滤液浓缩至干。按处方比例，将上述三种干粉混合。
134. 102475738 复方丹参制剂在制备抗肺动脉高压药物中的应用
CN
30.05.2012
A61K 36/537 Loading...
A61K 36/537
Loading...
201010555939.6
天士力制药集团股份有限公司
朱永宏
A61K 36/537
Loading...
本发明属于医药领域，涉及一种复方丹参制剂在制备抗肺动脉高压药物中的应用，本发明利用野百合碱和低压氧仓在大鼠上复制肺动脉高压模型，采用复方丹参滴丸进行治疗给药，实验数据表明，复方丹参滴丸可以显著降低模型动物的肺动脉高压，病理显示了良好的抗肺动脉血管增生作用，且改善肺动脉高压动物的肺动脉环舒张性。复方丹参滴丸可以作为预防和治疗肺动脉高压及相关疾病的理想药物。
135. 102464581 一种制备丹参素钠的方法
CN
23.05.2012
C07C 59/52 Loading...
C07C 59/52
Loading...
201010541632.0
天士力制药集团股份有限公司
靳元鹏
C07C 59/52
Loading...
本发明涉及一种制备高纯度丹参素钠的方法，该方法包括以下步骤：1)丹参素钠的提取2)丹参素的分离3)丹参素的转化成盐4)丹参素钠的分离5)丹参素钠的粘制与纯化。
136. 102464586 一种丹酚酸A的制备方法
CN
23.05.2012
C07C 69/732 Loading...
C07C 69/732
Loading...
201010541651.3
天士力制药集团股份有限公司
罗学军
C07C 69/732
Loading...
本发明涉及一种丹酚酸A的制备方法，该方法包括以下步骤：步骤一、提取丹参加乙醇提取；步骤二、粗分离用填装有AB-8大孔吸附树脂的色谱柱对丹酚酸A进行粗分离；步骤三、脱色用聚酰胺柱脱色；步骤四、纯化用MCI-GEL反相精细分离柱和葡聚糖凝胶LH-20柱进一步纯化；步骤五、干燥冷冻干燥。
137. 102441058 一种养血清脑颗粒的气相色谱指纹图谱检测方法
CN
09.05.2012
A61K 36/804 Loading...
A61K 36/804
Loading...
201010506123.4
天津天士力制药股份有限公司
高钧
A61K 36/804
Loading...
本发明提供一种获得养血清脑颗粒指纹图谱的方法，经过以下步骤：(1)养血清脑颗粒供试溶液的制备：取养血清脑颗粒，用水蒸气蒸馏法提取，用乙酸乙酯溶解挥发油成分；(2)将步骤(1)得到的挥发油注入气相色谱仪进行测定，得到其色谱图。本发明根据的养血清脑颗粒自身特点，采用气相色谱法测定养血清脑颗粒的指纹图谱，找到了优化的色谱条件，使测定结果精密，重复性好，稳定性良好。
138. 102441057 一种养血清脑颗粒的HPLC指纹图谱检测方法
CN
09.05.2012
A61K 36/804 Loading...
A61K 36/804
Loading...
201010506121.5
天津天士力制药股份有限公司
高钧
A61K 36/804
Loading...
一种养血清脑颗粒的HPLC指纹图谱检测方法，其特征在于，经过以下步骤：1)养血清脑颗粒供试品溶液的制备，精密称定养血清脑颗粒用3∶1甲醇-水配制成溶液，作为制剂供试品溶液；2)将步骤1得到的溶液注入高效液相色谱仪进行测定，分别得到它的色谱图。本发明根据的养血清脑颗粒自身特点，我们采用高效液相色谱法测定养血清脑颗粒的指纹图谱，找到了优化的色谱条件，使测定结果精密，重复性和稳定性良好。
139. 102370902 一种治疗肾病的药物及其制备方法
CN
14.03.2012
A61K 36/899 Loading...
A61K 36/899
Loading...
201010261854.7
天津天士力制药股份有限公司
周桂荣
A61K 36/899
Loading...
本发明涉及一种治疗肾病的药物及其制备方法，属于中药领域，本发明的药物，其特征在于：其活性成分由下列重量份数的原料制成：黄芪30-50份 益母草30-50份 白茅根10-30份 萹蓄10-30份 瞿麦10-30份 小蓟10-30份 石韦5-15份 地榆炭5-15份 土大黄10-30份 甘草2-4份，其制备方法如下：(1)黄芪水提醇沉过大孔树脂柱，得黄芪提取物；(2)益母草加水或醇-水溶剂提取，过离子交换树脂柱，得益母草提取物；(3)土大黄加水或醇-水溶剂提取，过大孔吸附树脂或聚酰胺树脂柱得土大黄提取物；(4)小蓟、白茅根、萹蓄、瞿麦、石韦、地榆炭、甘草七味药材水提醇沉，得七味提取物；(5)以上步骤得到的四种提取物，混匀，即得药物活性物质，以药物活性物质作为药物有效成分，用制剂学常规技术制备成制剂。
140. 102370699 芪参益气滴丸在制备改善心肌纤维化和心肌肥厚的药物中的应用
CN
14.03.2012
A61K 36/537 Loading...
A61K 36/537
Loading...
201010250622.1
天津天士力制药股份有限公司
韩晶岩
A61K 36/537
Loading...
本发明涉及芪参益气滴丸在制备改善心肌纤维化和心肌肥厚的药物中的应用，芪参益气滴丸是以现代科技提取黄芪、丹参、三七、降香中的有效成分精制而成的滴丸制剂，本发明的目的在于提供芪参益气滴丸在制备改善心肌纤维化，抑制心肌的进一步肥大的药物中的应用的药物中的应用，本发明所述应用是在左心室肥厚发生后，芪参益气滴丸可以改善心肌纤维化，本发明所述应用是在左心室肥厚发生后，可以显著地抑制左心室舒张末期室壁厚度和心脏体重指数的增加，增加左心室射血分数和缩短分数，减少心肌纤维化范围。
141. 102370700 丹参总酚酸在制备抑制血管内皮细胞吞饮小泡形成的药物中的应用
CN
14.03.2012
A61K 36/537 Loading...
A61K 36/537
Loading...
201010250625.5
天津天士力制药股份有限公司
韩晶岩
A61K 36/537
Loading...
本发明属于医药应用领域，具体涉及丹参总酚酸在制备抑制血管内皮细胞吞饮小泡形成的药物中的应用，丹参总酚酸通过抑制血管内皮细胞吞饮小泡形成，从而抑制缺血再灌注引起肠系膜细静脉血浆白蛋白的漏出。
142. 102370901 一种治疗肾病的药物组合物及其制备方法
CN
14.03.2012
A61K 36/899 Loading...
A61K 36/899
Loading...
201010261828.4
天津天士力制药股份有限公司
周桂荣
A61K 36/899
Loading...
本发明涉及一种治疗肾病的药物组合物及其制备方法，属于中药领域，本发明的治疗肾病的药物组合物，由下述重量份数的药材制成：黄芪30-50份 益母草30-50份 白茅根10-30份 萹蓄10-30份 瞿麦10-30份，小蓟10-30份 石韦5-15份 地榆炭5-15份 土大黄10-30份 甘草2-4份。
143. 102370903 一种治疗肾病的药物组合物及制备方法
CN
14.03.2012
A61K 36/899 Loading...
A61K 36/899
Loading...
201010261864.0
天士力制药集团股份有限公司
周桂荣
A61K 36/899
Loading...
本发明涉及一种治疗肾病的药物组合物及制备方法，属于中药领域，本发明的中药组合物，由下述重量份数的药材制成：黄芪30-50份 益母草30-50份 白茅根10-30份 萹蓄10-30份 瞿麦10-30份，小蓟10-30份 石韦5-15份 地榆炭5-15份 土大黄10-30份 甘草2-4份，其制备方法如下：(1)黄芪，加水提取，(2)土大黄和小蓟，加乙醇提取，(3)益母草、白茅根、萹蓄、瞿麦、石韦、地榆炭、甘草七味药材水提醇沉，(4)以上各步骤得到的提取物，按比例混匀，即得药物活性物质，以药物活性物质作为药物有效成分，用制剂学常规技术制备成制剂。
144. 202144309 机械手单元及带有该机械手单元的生产线
CN
15.02.2012
B65B 61/24 Loading...
B65B 61/24
Loading...
201120201212.8
天津天士力制药股份有限公司
李国华
B65B 61/24
Loading...
一种机械手单元，包括机架、动力源和控制装置，动力源和控制装置相连并受其控制，机架上设有夹板装置，包括固定板，固定板上设有支撑杆，支撑杆与夹板臂铰接，夹板臂包括上夹板臂和下夹板臂，上夹板臂上设有开槽，下夹板臂的末端设有夹板，上夹板臂的开槽内滑动设置拨叉的一端，拨叉的另一端与第一动力源相连并在其驱动下产生竖直方向上的往复运动；固定板与第二动力源相连并在其驱动下使夹板装置产生水平方向上的往复运动；机架上还设有工作道。一种生产线，传送带中间隔设置机械手单元，相邻的两个机械手单元的工作道之间设有挡板。本实用新型结构简单，操作方便，作业位置准确，产品拿取的同时一并对其整形，连续生产且生产效率高，可控性强。
145. WO/2012/016549 USE OF SALVIA MILTIORRHIZA COMPOSITION IN PREPARING DRUGS FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE
WO
09.02.2012
A61K 36/53 Loading...
A61K 36/53
Loading...
PCT/CN2011/078128
TASLY PHARMACEUTICAL GROUP CO., LTD.
YAN, Xijun
A61K 36/53
Loading...
Provided is the use of a Salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease, and particularly the use of the Salvia miltiorrhiza composition in preparing drugs for secondary prevention of stable angina type coronary heart disease and the reduction of serious vascular events.
146. WO/2012/003804 PHARMACEUTICAL COMPOSITION OF SILYBIN AND PREPARATION METHOD THEREOF
WO
12.01.2012
A61K 9/08 Loading...
A61K 9/08
Loading...
PCT/CN2011/076988
TASLY PHARMACEUTICAL GROUP CO., LTD.
CHEN, Jianming
A61K 9/08
Loading...
A pharmaceutical composition of silybin and a preparation method thereof. The pharmaceutical composition comprises a silybin infusion solution and a liquid infusion solvent; both are respectively held in a container and packaged together. The silybin infusion solution comprises an active ingredient, a phospholipid, and infusion solvent A. The liquid infusion solvent comprises a bile salt and infusion solvent B.
147. 102309441 一种水飞蓟宾药物组合包装物及其制备方法
CN
11.01.2012
A61K 9/08 Loading...
A61K 9/08
Loading...
201010222910.6
天津天士力制药股份有限公司
陈建明
A61K 9/08
Loading...
本发明属于医药领域，涉及一种稳定性好、疗效显著水飞蓟宾组合包装物及其制备方法。本发明所述药物组合物包装，包括水飞蓟宾注射溶液和注射溶媒，两者分别装载在各自的容器中，组合包装在一起。临床使用前将溶媒与水飞蓟宾溶液混匀后稀释于5％葡萄糖或10％葡萄糖注射溶液中进行滴注，这样简化了水飞蓟宾注射剂的制备过程，降低了制备成本，使得水飞蓟宾注射剂的规模化生产简单可行。
148. WO/2012/000425 USE OF A CHINESE MEDICINE COMPOSITION IN PREPARING MEDICAMENTS FOR TREATING SECONDARY PREVENTION OF MYOCARDIAL INFARCTION
WO
05.01.2012
A61K 36/537 Loading...
A61K 36/537
Loading...
PCT/CN2011/076499
TASLY PHARMACEUTICAL GROUP CO., LTD.
ZHANG, Boli
A61K 36/537
Loading...
A use of a chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction. The composition is prepared with the following crude drugs by weight percent: Radix Astragali 22.2%~66.8%, Radix Salviae Miltiorrhizae 11.6%~33.4%, Radix Notoginseng 2.5%~13.5%, Lignum Dalbergiae Odoriferae 14.5%~44.3%.
149. 202096469 滴丸脱油干燥机
CN
04.01.2012
A61J 3/06 Loading...
A61J 3/06
Loading...
201120062898.7
天津天士力制药股份有限公司
李常洪
A61J 3/06
Loading...
一种滴丸脱油干燥机，包括支架(1)和固定在支架(1)上的转筒(2)，转筒(2)在第一电机的驱动下旋转，转筒上设有进出料口(21)，所述的转筒(2)内壁敷设有粘附介质，所述的转筒(2)内部设有集液装置，所述的集液装置包括第一刮刀(3)，所述的第一刮刀(3)的刀刃与转筒(2)内壁的粘附介质表面接触，所述的第一刮刀(3)与第一收集管相连；所述的转筒(2)内部设有转轮(5)，所述的转轮(5)在第二电机的驱动下旋转，转轮(5)的外表面与所述转筒(2)的内壁之间间隔设置，间隔为20～80mm。本实用新型结构简单，操作方便，依靠介质的粘附作用，有效清除滴丸表面的液态残留物，拆装方便，实现连续生产且生产效率高，可控性强。
150. 102293822 Application of traditional Chinese medicine composition in preparation of medicines used for reducing occurrence of cardiovascular events after acute myocardial infarction
CN
28.12.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
201010527505.5
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhang Boli
A61K 36/537
Loading...
The invention relates to an application of a traditional Chinese medicine composition in the preparation of medicines used in acute myocardial infarction secondary prevention. The acute myocardial infarction secondary prevention means the reduction of the occurrences of cardiovascular events after acute myocardial infarction. The composition is prepared from raw medicines of, by weight: 22.2% to 66.8% of astragalus membranaceus, 11.6% to 33.4% of salvia miltiorrhiza, 2.5% to 13.5% of panax notoginseng, and 14.5% to 44.3% of rosewood heart wood.
151. 102293820 Use of traditional Chinese drug composition in preparing drugs for reducing death incidents of myocardial infarction patients
CN
28.12.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
201010527420.7
天士力制药集团股份有限公司
张伯礼
A61K 36/537
Loading...
The invention relates to a use of a traditional Chinese drug composition in preparing drugs for secondary prevention of myocardial infarction. The secondary prevention of the myocardial infarction is that: the generation of death incidents of myocardial infarction patients is reduced. The composition is prepared through the following crude drugs, by weight, 22.2-66.8% of mongolian milkvetch root, 11.6-33.4% of salvia miltiorrhiza, 2.5-13.5% of panax notoginseng and 14.5-44.3% of rosewood heart wood.
152. 102293824 Application of traditional Chinese medicine composition in preparing medicines for improving life quality of patient suffering from acute myocardial infarction
CN
28.12.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
201010527535.6
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhang Boli
A61K 36/537
Loading...
The invention relates to application of a traditional Chinese medicine composition in preparing medicines for secondary prevention of myocardial infarction. The secondary prevention of myocardial infarction is to improve the life quality of a patient suffering from myocardial infarction. The composition is prepared from the following active pharmaceutical ingredients in percentage by weight: 22.2-66.8% of radix astragali, 11.6-33.4% of radix salviae miltiorrhizae, 2.5-13.5% of pseudo-ginseng and 14.5-44.3% of dalbergia wood.
153. 102293823 Application of traditional Chinese medicine composition in preparing medicines for secondary prevention of myocardial infarction
CN
28.12.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
201010527526.7
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhang Boli
A61K 36/537
Loading...
The invention relates to application of a traditional Chinese medicine composition in preparing medicines for secondary prevention of myocardial infarction. The composition is prepared from the following active pharmaceutical ingredients in percentage by weight: 22.2-66.8% of radix astragali, 11.6-33.4% of radix salviae miltiorrhizae, 2.5-13.5% of pseudo-ginseng and 14.5-44.3% of dalbergia wood.
154. 102293821 Application of traditional Chinese medicine composite in preparing medicine for relieving acute myocardial postinfarction angina pectoris
CN
28.12.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
201010527436.8
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhang Boli
A61K 36/537
Loading...
The invention relates to an application of a traditional Chinese medicine composite in preparing a medicine for relieving acute post-MI (myocardial infarction) angina pectoris. Secondary prevention of MI refers to the relief of the angina pectoris for acute post-MI patients. The composite comprises the following raw materials in percentage by weight: 22.2-66.8% of Astragalus mongholicus, 11.6-33.4% of Salvia miltiorrhiza, 2.5-13.5% of pseudo-ginseng and 14.5-44.3% of lignum dalbergiae odoriferae.
155. WO/2011/140981 USE OF 5'-METHOXY-3',4'-METHYLENEDIOXYCINNAMIC ACID ISOBUTYLAMIDE ON PREPARING MEDICAMENTS FOR ANTI-DEPRESSION
WO
17.11.2011
A61K 31/16 Loading...
A61K 31/16
Loading...
PCT/CN2011/073937
TASLY PHARMACEUTICAL GROUP CO., LTD.
MA, Xiaohui
A61K 31/16
Loading...
The use of 5'-methoxy-3',4'-methylenedioxycinnamic acid isobutylamide or pharmaceutical compositions containing the compound on preparing medicaments for preventing or treating depression is provided by the present invention. The extraction and purification process of the compound from piper plant is also provided by the present invention.
156. 102241574 Method for preparing high-purity protocatechualdehyde from salvia miltiorrhiza
CN
16.11.2011
C07C 47/565 Loading...
C07C 47/565
Loading...
201010169711.3
Tianjin Tasly Pharmaceutical Co., Ltd.
Jin Yuanpeng
C07C 47/565
Loading...
The invention belongs to field of medicines and relates to a method for preparing high-purity protocatechualdehyde. The preparation method comprises the following steps: 1, preparing salvia miltiorrhiza extract by alkaline extraction and alcohol precipitation; 2, removing salvia miltiorrhiza components with relatively weak polarity by chromatography; 3, separating protocatechualdehyde by chromatography; 4, removing acid and decoloring; 5, refining and purifying; and 6, drying.
157. 102240281 Application of 5'-methoxy-3',4'-methylenedioxy cinnamic acid isobutyl amide in preparing antidepressant medicaments
CN
16.11.2011
A61K 31/36 Loading...
A61K 31/36
Loading...
201010169679.9
Tianjin Tasly Pharmaceutical Co., Ltd.
Ma Xiaohui
A61K 31/36
Loading...
The invention belongs to the field of traditional Chinese medicine preparation, and relates to application of an amide compound 5'-methoxy-3',4'-methylenedioxy cinnamic acid isobutyl amide extracted from plants in preparing antidepressant medicaments.
158. 102241661 Preparation method of compound 5'-methoxy-3',4'-methylenedioxy cinnamic acid iso-butyl amide
CN
16.11.2011
C07D 317/64 Loading...
C07D 317/64
Loading...
201010169699.6
Tianjin Tasly Pharmaceutical Co., Ltd.
Luo Xuejun
C07D 317/64
Loading...
The invention belongs to the field of traditional Chinese medicine pharmacy, and relates to a preparation method of high-purity amide compound 5'-methoxy-3',4'-methylenedioxy cinnamic acid iso-butyl amide by extracting from Piper plants. The preparation method provided by the invention comprises the following steps: (1) extraction: adding medicinal materials into an extraction tank, adding a solvent for extraction, filtering, and concentrating the extraction liquid to obtain an extract; (2) refining: dissolving the extract with a solvent, adding the dissolved extract to a chromatographic column, eluting, collecting the eluate, and concentrating the eluate to be dry to obtain an extract; and (3) separation and purification: dissolving the extract with a solvent, adding the dissolved extract to a chromatographic column, eluting, detecting by thin-layer chromatography, combining the eluate containing 5'-methoxy-3',4'-methylenedioxy cinnamic acid iso-butyl amide, concentrating the combined eluate, recrystallizing, and drying to obtain 5'-methoxy-3',4'-methylenedioxy cinnamic acid iso-butyl amide.
159. 102233074 Application of medicine composition in preparing functional medicines for protecting islet belta cells
CN
09.11.2011
A61K 36/8888 Loading...
A61K 36/8888
Loading...
201010156316.1
Tianjin Tasly Pharmaceutical Co., Ltd.
Tong Xiaolin
A61K 36/8888
Loading...
The invention, belonging to the filed of pharmacy, relates to an application of a medicine composition in preparing functional medicines for protecting islet belta cells. The medicine composition comprises the following Chinese medicine raw materials as ingredients: 5-40 weight portions of root of Chinese trichosanthes, 10-30 weight portions of radix bupleuri, 3-15 weight portions of immature bitter orange, 1-6 weight portions of raw rhubarb, 1-12 weight portions of pinellia ternate, 3-15 weight portions of scutellaria baicalensis, 1-12 weight portions of coptis, 3-15 weight portions of white peony root and 5-20 weight portions of dark plum.
160. 102233075 Use of medicinal composition in preparation of medicine for improving disorder of carbohydrate metabolism by regulating adenosine monophosphate -activated protein kinase (AMPK)-glucose transporter type 4(GLUT4)
CN
09.11.2011
A61K 36/8888 Loading...
A61K 36/8888
Loading...
201010156322.7
Tianjin Tasly Pharmaceutical Co., Ltd.
Tong Xiaolin
A61K 36/8888
Loading...
The invention belongs to the field of pharmacy and relates to use of a medicinal composition in the preparation of a medicine for improving activity of AMPK in skeletal muscle. The medicinal composition is prepared according to a formula comprising the following raw material medicines in Chinese medicine in part by weight: 5 to 40 parts of mongolian snakegourd root, 10 to 30 parts of Chinese thorowax root, 3 to 15 parts of fruit of immature citron, 1 to 6 parts of raw Chinese rhubarb, 1 to 12 parts of Pinellia ternate, 3 to 15 parts of Scutellaria baicalensis, 1 to 12 parts of Coptis chinensis, 3 to 15 parts of white paeony root and 5 to 20 parts of dark plum.
161. 102233077 Use of medicinal composition in preparation of medicine for improving activity of adenosine 5'-monophosphate-activated protein kinase (AMPK)
CN
09.11.2011
A61K 36/8888 Loading...
A61K 36/8888
Loading...
201010156332.0
Tianjin Tasly Pharmaceutical Co., Ltd.
Tong Xiaolin
A61K 36/8888
Loading...
The invention belongs to the field of pharmacy and relates to the use of a medicinal composition in the preparation of a medicine for improving the activity of AMPK. The medicinal composition is prepared according to a formula consisting of the following Chinese medicinal raw materials in part by weight: 5 to 40 parts of mongolian snakegourd root, 10 to 30 parts of root of Chinese thorowax, 3 to 15 parts of immature bitter orange, 1 to 6 parts of raw rheum officinale, 1 to 12 parts of pinellia ternate, 3 to 15 parts of root of scutellaria baicalensis, 1 to 12 parts of coptis chinensis, 3 to 15 parts of white paeony root and 5 to 20 parts of dark plum.
162. 102233076 Application of pharmaceutical composition in preparing medicament for treating type 2 diabetes mellitus due to lipotoxicity by reducing SREBP1-C
CN
09.11.2011
A61K 36/8888 Loading...
A61K 36/8888
Loading...
201010156324.6
天士力制药集团股份有限公司
仝小林
A61K 36/8888
Loading...
The invention belongs to the medical field, and relates to an application of a pharmaceutical composition in preparing a medicament for reducing SREBP1-c, wherein the pharmaceutical composition is prepared by the following traditional Chinese medicine raw materials by weight: 540 parts of trichosanthin, 10-30 parts of radix bupleuri, 3-15 parts of citrus aurantium, 1-6 parts of raw rhubarb, 1-12 parts of pinellia tuberifera, 3-15 parts of radix scutellariae, 1-12 parts of coptis, 3-15 parts of white peony roots, and 5-20 parts of dark plums.
163. 102233078 Use of medicinal composition in preparation of medicine for regulating and improving microenvironment of pancreas islet
CN
09.11.2011
A61K 36/8888 Loading...
A61K 36/8888
Loading...
201010156334.X
天士力制药集团股份有限公司
仝小林
A61K 36/8888
Loading...
The invention belongs to the field of pharmacy and relates to the use of a medicinal composition in the preparation of a medicine for improving the microenvironment of pancreas islet. The medicinal composition is prepared according to a formula consisting of the following raw material medicines in Chinese medicine in part by weight: 5 to 40 parts of mongolian snakegourd root, 10 to 30 parts of Chinese thorowax root, 3 to 15 parts of fruit of immature citron, 1 to 6 parts of raw Chinese rhubarb, 1 to 12 parts of Pinellia ternate, 3 to 15 parts of Scutellaria baicalensis, 1 to 12 parts of Coptis chinensis, 3 to 15 parts of white paeony root and 5 to 20 parts of dark plum.
164. 102210669 Application of salvia extract in treating septicemia
CN
12.10.2011
A61K 31/343 Loading...
A61K 31/343
Loading...
201110166125.8
Tianjin Tasly Pharmaceutical Co., Ltd.
Han Jingyan
A61K 31/343
Loading...
The invention relates to an application of a salvia extract in treating septicemia, in particular to an application of the salvia extract, namely dihydroxyl phenyl lactic acid or salvianolic acid B in treating and/or preventing septicemia.
165. 102180932 Method for preparing steroid saponin DT-13
CN
14.09.2011
C07J 21/00 Loading...
C07J 21/00
Loading...
201110077480.8
China Pharmaceutical University
Yu Boyang
C07J 21/00
Loading...
The invention relates to the technical field of Chinese medicine extracting and separating processes, in particular to a method for extracting and separating steroid saponin DT-13 from the underground part of liriope muscari. In the method, a repeated purification process by Sephadex LH-20 and ODS in the prior art is eliminated. The method comprises the following separation steps of: performing ethanol extraction of the underground part of liriope muscari, performing macroporous resin column chromatography of extracting solution, eluting the chromatographic column by using ethanol, concentrating the eluent, removing impurities through extraction, performing silica gel column chromatographic separation of a water layer obtained after impurity removal, performing re-crystallization and the like. The improved extraction method has the advantages of simple and practicable process, much low cost and high yield (about 1.1 to 1.4 percent).
166. WO/2011/103789 CAPSULE OF COMPLEX DANSHEN DROP PILL
WO
01.09.2011
A61K 9/48 Loading...
A61K 9/48
Loading...
PCT/CN2011/071050
TASLY PHARMACEUTICAL GROUP CO., LTD.
SUN, He
A61K 9/48
Loading...
A capsule of complex danshen drop pill is disclosed. The color of the capsule's shell is orange, yellow, green or blue and all of these colors are in the wavelength range of 446nm-620nm.
167. 102160872 Compound salvia dropping pill capsules
CN
24.08.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
201010112014.4
Tianjin Tasly Pharmaceutical Co., Ltd.
Sun He
A61K 36/537
Loading...
The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a medicinal capsule preparation prepared by processing capsule shells having different colors and made of different materials. The capsule shells have colors; and a medicine is compound salvia dropping pills. The compound salvia dropping pill capsules are favorable for maintaining the physicochemical properties of the compound salvia dropping pills and the stability of active ingredients.
168. 102144994 Antiplatelet aggregative activity of compound extracted from dalbergia wood
CN
10.08.2011
A61K 31/341 Loading...
A61K 31/341
Loading...
201019102001.6
Tianjin Tasly Pharmaceutical Co., Ltd.
Cheng Yiyu
A61K 31/341
Loading...
The invention relates to an antiplatelet aggregative activity of a compound extracted from a dalbergia wood, wherein the compound is 3, 7, 11-trimethyl-3, 6-oxo-1, 10-dodecadiene-7-alcohol and an isomer thereof.
169. 102133239 Chinese medical concentrated pill and preparation method thereof
CN
27.07.2011
A61K 47/38 Loading...
A61K 47/38
Loading...
201010031397.2
Tianjin Tasly Pharmaceutical Co., Ltd.
Yang Jianhui
A61K 47/38
Loading...
The invention belongs to the medicine field, in particular relates to a Chinese medical pill and a preparation method thereof. The Chinese medical pill is prepared from medical powder, high-plasticity and low-viscosity excipients and low-melting-point water-soluble auxiliary materials.
170. 102119961 Detection method of compound danshen dripping pills
CN
13.07.2011
G01N 30/90 Loading...
G01N 30/90
Loading...
201010031312.0
Tianjin Tasly Pharmaceutical Co., Ltd.
Sun Wei
G01N 30/90
Loading...
The invention relates to a detection method of compound danshen dripping pills, comprising the following contents of: observation of characters, discrimination of contents, inspection of contents, comparison of finger prints and assaying of contained components. The detection method provided by the invention comprises a discriminating method of the medicinal component panax notoginseng, the discriminating method adopts thin-layer chromatography, the reference materials adopt a panax notoginseng reference medicinal material, a ginsenoside Rg1 reference substance, a ginsenoside Re reference substance, a ginsenoside Rb1 reference substance and a panax notoginseng saponin R1 reference substance. The detection method provided by the invention also comprises a discriminating method and an assaying method of the medicinal component danshen, wherein the discriminating method adopts a sub-2 mu m liquid chromatography technology to perform chromatographic fingerprint discrimination, and adopts sodium danshensu as a reference material; and the assaying method adopts a sub-2 mu m liquid chromatography technology to perform assaying on the components such as danshensu, panax notoginseng saponin R1, ginsenoside Rg1 and ginsenoside Rb1 in the danshen.
171. WO/2011/072619 TRADITIONAL CHINESE DRUG COMPRISING DANSHEN EXTRACTS AND SANQI EXTRACTS AND USE THEREOF
WO
23.06.2011
A61K 31/192 Loading...
A61K 31/192
Loading...
PCT/CN2010/079928
TASLY PHARMACEUTICAL GROUP CO., LTD.
HAN, Jingyan
A61K 31/192
Loading...
The present invention discloses a traditional chinese drug consisting of Danshen extracts and Sanqi extracts, the pharmaceutical composition comprising the above traditional chinese drug as active component and the use thereof. The traditional chinese drug consists of Danshen extracts and Sanqi extracts by weight ratio of (2-6):(0.5-2). The invention further discloses the effect of the traditional chinese drug and the pharmaceutical composition comprising the above traditional chinese drug as active component for treating cardiac microcirculation disturbance and myocardial damage induced by ischemia reperfusion.
172. 102100738 Application of compound danshen dripping pills in preparation of medicines for treating microcirculation disturbance and myocardial fibrosis
CN
22.06.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
200910244836.5
Tianjin Tasly Pharmaceutical Co., Ltd.
Han Jingyan
A61K 36/537
Loading...
The invention discloses application of compound danshen dripping pills in preparation of medicines for treating microcirculation disturbance and myocardial fibrosis. The compound danshen dripping pills are administrated after heart ischemia reperfusion so as to effectively treat myocardial fibrosis injury caused by the ischemia reperfusion and improve heart microcirculation disturbance caused by improving the ischemia reperfusion.
173. 102100739 Chinese medicinal composition containing salvianic acid A and pseudoginseng root saponin R1 and application thereof
CN
22.06.2011
A61K 31/192 Loading...
A61K 31/192
Loading...
200910244837.X
Tianjin Tasly Pharmaceutical Co., Ltd.
Han Jingyan
A61K 31/192
Loading...
The invention discloses a Chinese medicinal composition containing salvianic acid A and application thereof. The composition consists of an extract of the root of red-rooted salvia and a pseudoginseng root extract in a weight ratio of (2-6):(0.5-2). Meanwhile, the invention discloses application of the Chinese medicinal composition in improving heart microcirculation disturbance and myocardial damage caused by ischemic reperfusion.
174. 102060885 Preparation method for forsythoside A
CN
18.05.2011
C07H 15/18 Loading...
C07H 15/18
Loading...
200910228550.8
Tianjin Tasly Pharmaceutical Co., Ltd.
Hu Chenxu
C07H 15/18
Loading...
The invention discloses a preparation method for forsythoside A. The preparation method for the forsythoside A comprises the following steps of: (1) immersing raw material medicament in acid, and extracting; (2) separating by using resin; (3) separating by using polyamide; (4) separating by using resin; (5) purifying by using reverse phase silica gel; and (6) purifying by using dextrangel. According to the method, an alcohol-water system is used for extraction and separation, and resin materials used in the process are recycled, so the production cost is reduced. By the extraction method of the preparation method for the forsythoside A, the content of the final product forsythoside A is up to 90 to 95 percent; therefore, the process is simple and efficient, and is suitable for industrial production.
175. 102058645 Ginseng glycoside H extractive and preparation method thereof
CN
18.05.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910228461.3
Tianjin Tasly Pharmaceutical Co., Ltd.
Song Zhaohui
A61K 36/258
Loading...
The invention relates to a Chinese medicine extractive and a preparation method thereof, in particular to a ginseng glycoside H extractive and a preparation method thereof. The extractive of the invention contains 5%-25% of ginsenoside Rh1 and 20%-40% of ginsenoside Rh2. Total contents of ginseng glycoside and ginsenoside Rh2 are not less than 60% and total contents of the ginsenoside Rh1 and the ginsenoside Rh2 are not less than 40%.
176. 102058642 Ginseng saponin extract and preparation method thereof
CN
18.05.2011
A61K 31/704 Loading...
A61K 31/704
Loading...
200910228458.1
Tianjin Tasly Pharmaceutical Co., Ltd.
Song Zhaohui
A61K 31/704
Loading...
The invention relates to a traditional Chinese medicine extract and a preparation method thereof, in particular to a Ginseng saponin extract and a preparation method thereof. In the extract, the content of protodioscin is not less than 80 percent based on that of Ginseng saponin Rh2, the content of Ginseng saponin Rh1 and the Ginseng saponin Rh2 is not less than 50 percent, the content of Ginseng saponin Rh1 is between 1 and 20 percent and the content of the Ginseng saponin Rh2 is between 20 and 60 percent.
177. 102058000 Instant milk tea
CN
18.05.2011
A23F 3/30 Loading...
A23F 3/30
Loading...
200910228466.6
Tianjin Tasly Pharmaceutical Co., Ltd.
Sun Yan
A23F 3/30
Loading...
The invention relates to a tea product, in particular to a formula and a preparation method of instant milk tea. The instant milk tea comprises tea powder, milk powder and sucralose.
178. 102058646 Ginsenoside Rh2 extract and preparation method thereof
CN
18.05.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910228462.8
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhang Lanlan
A61K 36/258
Loading...
The invention relates to traditional Chinese medicine extract and preparation thereof, in particular to ginsenoside Rh2 extract and preparation thereof. The preparation method comprises the following steps of: 1, extracting a medicinal material which contains ginsenoside components by using water, performing column chromatography on extract liquid through a macroporous adsorption resin column, eluting by using ethanol, collecting eluent, and concentrating the eluent until the eluent is dried so as to obtain total saponins; 2, dissolving the total saponins obtained in the step 1 in acid solution for reaction, adjusting pH to be neutral after the reaction is completed, and collecting precipitate; and 3, dissolving the precipitate in the ethanol, mixing into reverse phase silica gel, performing reverse phase silica gel column chromatography, eluting by using acetonitrile and water mixed liquid, collecting a fraction which is rich in the ginsenoside Rh2, and concentrating the fraction to obtain the ginsenoside Rh2 extract. The prepared ginsenoside Rh2 extract has higher treatment effect and higher purity than that prepared by the prior art.
179. 102058644 Ginseng saponin H extract and preparation method thereof
CN
18.05.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910228460.9
Tianjin Tasly Pharmaceutical Co., Ltd.
Song Zhaohui
A61K 36/258
Loading...
The invention relates to a traditional Chinese medicine extract and a preparation method thereof, in particular to a Ginseng saponin H extract and a preparation method thereof. In the extract, the content of Ginseng saponin Rh1 is between 1 and 15 percent, the content of Ginseng saponin Rh2 is between 10 and 30 percent, the content of the Ginseng saponin Rh1 and the Ginseng saponin Rh2 is not less than 25 percent and the content of protodioscin is not less than 50 percent based on that of the Ginseng saponin Rh2.
180. 102058647 Ginseng glycoside H extract and preparation method thereof
CN
18.05.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910228486.3
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhang Lanlan
A61K 36/258
Loading...
The invention relates to a traditional Chinese medicine extract and a preparation method thereof, in particular to a ginseng glycoside H extract and a preparation method thereof. The extract contains 2 to 25 percent of ginsenoside Rh1 and 15 to 35 percent of ginsenoside Rh2; and the ginseng glycoside is not less than 60 percent based on the ginsenoside Rh2, and the sum of the ginsenoside Rh1 and the ginsenoside Rh2 is not less than 35 percent.
181. 102060903 Ginsenoside Rh2 extractive and preparation method thereof
CN
18.05.2011
C07J 17/00 Loading...
C07J 17/00
Loading...
200910228463.2
Tianjin Tasly Pharmaceutical Co., Ltd.
Song Zhaohui
C07J 17/00
Loading...
The invention relates to a Chinese medicine extractive and a preparation method thereof, in particular to a ginsenoside Rh2 extractive and a preparation method thereof. The preparation method of the extractive comprises the following steps of: 1, extracting the medicinal materials containing ginsenosides ingredients with water, depositing the extracting solution in alcohol and collecting supernatant fluid and concentrating to be dry to obtain total saponins; 2, dissolving the total saponins obtained in the step 1 in a buffer solution the PH of which is about 5, reacting by adding Beta-glucosaccharase, diluting a reaction solution after the reaction is finished, and collecting sediment; and 3, dissolving the sediment by ethanol and mixing in silica gel to perform silica gel column chromatography, eluting with a mixture of ethyl acetate and ethanol, collecting fractions rich in ginsenoside Rh2 and concentrating to obtain the ginsenoside Rh2 extractive.
182. 102058480 Oral effervescent tablet and preparation method thereof
CN
18.05.2011
A61J 3/10 Loading...
A61J 3/10
Loading...
200910228467.0
Tianjin Tasly Pharmaceutical Co., Ltd.
Yang Jianhui
A61J 3/10
Loading...
The invention relates to an oral effervescent tablet and a preparation method thereof, belonging to the field of pharmaceutic preparations. The preparation method of the effervescent tablet provided by the invention comprises the following steps: mixing raw materials, and pelletizing; and tidying particles, tabletting and the like.
183. 102060884 Preparation method of forsythoside A
CN
18.05.2011
C07H 15/18 Loading...
C07H 15/18
Loading...
200910228549.5
Tianjin Tasly Pharmaceutical Co., Ltd.
Hu Chenxu
C07H 15/18
Loading...
The invention discloses a preparation method of forsythoside A, comprising the following steps of: (1) extraction; (2) alcohol precipitation; (3) separation; (4) purification; and (5) enrichment. The preparation method has the advantages of simple and safe process, no pollution, more convenience for production and operation, capability of realizing mass production, conformity to industrial requirement, lower cost, reliable and stable process data, good reproducibility, strong controllability for process, and conformity to GMP (Good Manufacturing Practice) production requirement.
184. 102058643 Ginseng saponin H extract and preparation method thereof
CN
18.05.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910228459.6
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhang Lanlan
A61K 36/258
Loading...
The invention relates to a traditional Chinese medicine extract and a preparation method thereof, in particular to a Ginseng saponin H extract and a preparation method thereof. In the extract, the content of protodioscin is not less than 60 percent based on that of Ginseng saponin Rh2 and the content of the Ginseng saponin Rh1 and the Ginseng saponin Rh2 is not less than 30 percent.
185. WO/2011/054301 USE OF DANSHENSU, NOTOGINSENOSIDE R1 OR THEIR COMBINATION IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING DISEASES CAUSED BY MICROCIRCULATION DISORDER
WO
12.05.2011
A61K 31/192 Loading...
A61K 31/192
Loading...
PCT/CN2010/078411
TIANJIN TASLY PHARMACEUTICAL CO., LTD.
HAN, Jingyan
A61K 31/192
Loading...
Use of danshensu, notoginsenoside R1 or their combination in the preparation of medicaments for preventing and treating diseases caused by microcirculation disorder.
186. 102048890 Traditional Chinese medicine composition with galactagogue effect and preparation method thereof
CN
11.05.2011
A61K 36/804 Loading...
A61K 36/804
Loading...
200910228131.4
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhou Guirong
A61K 36/804
Loading...
The invention relates to a traditional Chinese medicine composition with a galactagogue effect and a preparation method thereof, and the composition comprises membranous milkvetch root, Chinese angelica, radix rehmanniae preparata, cowherb seed, pig nails and beautiful sweetgum fruit.
187. 102048643 Dripping tank and pill dripping machine thereof
CN
11.05.2011
A61J 3/06 Loading...
A61J 3/06
Loading...
200910228132.9
Tianjin Tasly Pharmaceutical Co., Ltd.
Jin Donghui
A61J 3/06
Loading...
The invention relates to a dripping tank and a pill dripping machine thereof. The dripping tank comprises a tank body formed by a tank wall and a tank bottom, a tank cover is arranged above the tank body, an outer layer tank wall and an outer layer tank bottom are respectively arranged outside the tank body, the tank wall and the outer layer tank wall form a lateral cavity, the tank bottom and the outer layer tank bottom form a bottom cavity, a plurality of dripping heads are arranged in the bottom cavity, the lateral cavity and the bottom cavity are communicated with each other to form a heating cavity, an inflow pipe and a return conduit are connected to the heating cavity to form a circulation loop; a heater and a circulating pump are arranged on the circulation loop, heating medium is pumped from the heater via the circulating pump, is input from the inflow pipe, fills the heating cavity, returns to the heater for heating along the return conduit after the temperature drops, and is pumped to the inflow pipe via the circulating pump; and the heating medium heats the feed liquid in the tank body and the dripping heads through the heating cavity. The invention has the advantages of uniformity of heating, constant heating temperature and large heating surface, the purpose that the tank body and the dripping heads are heated fully is achieved, the feed liquid is prevented from being solidified due to temperature reduction, and continuous production and high production efficiency can be realized.
188. 102048720 Tanshinol and notoginsenoside R1, as well as application of compatibility thereof for preventing and treating diseases caused by microcirculation disturbance
CN
11.05.2011
A61K 31/192 Loading...
A61K 31/192
Loading...
200910071163.8
Tianjin Tasly Pharmaceutical Co., Ltd.
Han Jingyan
A61K 31/192
Loading...
The invention relates to traditional Chinese medicine products of tanshinol and notoginsenoside R1, as well as new application of compatibility of the tanshinol and the notoginsenoside R1, in particular to tanshinol and notoginsenoside R1, as well as an application of compatibility of the tanshinol and the notoginsenoside R1 in preventing and treating diseases caused by microcirculation disturbance.
189. 102048818 Total salvianolic acid, panax notoginseng saponins, and compatibility thereof in prevention and treatment of diseases caused by microcirculatory disturbance
CN
11.05.2011
A61K 36/537 Loading...
A61K 36/537
Loading...
200910071164.2
Tianjin Tasly Pharmaceutical Co., Ltd.
Han Jingyan
A61K 36/537
Loading...
The invention relates to total salvianolic acid and panax notoginseng saponins serving as Chinese medicinal products and new application of compatibility thereof, in particular to total salvianolic acid, panax notoginseng saponins, and compatibility thereof in prevention and treatment of diseases caused by microcirculatory disturbance.
190. 102048646 Pill dropping machine with dropping distance adjusting device
CN
11.05.2011
A61J 3/06 Loading...
A61J 3/06
Loading...
200910228135.2
Tianjin Tasly Pharmaceutical Co., Ltd.
Jin Donghui
A61J 3/06
Loading...
The invention discloses a pill dropping machine with a manual dropping distance adjusting device. The pill dropping machine comprises a stand upright of the pill dropping machine, wherein a suspension bracket is fixed at the top end of the stand upright; a suspension hanger is arranged below the suspension bracket; the suspension bracket and the suspension hanger are connected through an adjusting mechanism; a support frame is fixed at the bottom of the suspension hanger; a dropping tank is fixed on the support frame; the adjusting mechanism comprises a screw rod; one end of the screw rod is rotatably fixed in the middle part of the suspension bracket through an adjusting part; a nut sleeve is sleeved at the other end of the screw rod and fixed with the middle part of the suspension hanger; and the adjusting part drives the screw rod to rotate in the nut sleeve to change the height of the support frame. According to the invention, if adjustment is not frequent, excessive auxiliary structures and power match are not required; the pill dropping machine disclosed by the invention is more convenient to use, easy to maintain and beneficial to GMP (good manufacturing practice) management and sanitation; and moreover, optimal technical condition indexes are realized, and best pill type and product quality are obtained.
191. 102048648 Pill drilling machine
CN
11.05.2011
A61J 3/06 Loading...
A61J 3/06
Loading...
200910228137.1
Tianjin Tasly Pharmaceutical Co., Ltd.
Jin Donghui
A61J 3/06
Loading...
A pill drilling machine comprises a mainframe and an auxiliary machine, wherein the mainframe comprises a dripping device, a condensing device and a collecting device respectively fixed on a frame; the auxiliary machine comprises a control device and is electrically connected with the mainframe and controls each device for operation, one auxiliary machine can be electrically connected with one or more mainframes, and each device in each mainframe is respectively controlled through one auxiliary machine for operation; and 1 to 4 mainframes are included. The pill drilling machine has compact structure and reasonable layout, control systems are not arranged repeatedly, and the manufacturing cost of equipment is reduced greatly, the temperature required by the process is kept, the solidification of feed liquid is avoided, and the continuous production under stable pressure is ensured; dripping heads are connected tightly by adopting special fastening tool; the safe and closed on-line cleaning is realized, a suspension groove and a water receiving disc have simple structures and are convenient and fast to assemble and disassemble; the dripping distance is adjusted effectively, thereby being favorable for GMP (Good Manufacturing Practice) management and sanitation; and a semi-automatic control mode is adopted to ensure that the oil pill collection speed is high, the efficiency is high, the use is convenient, and the cleaning is easy.
192. 102048841 Lactogenic traditional Chinese medicine composition and preparation method thereof
CN
11.05.2011
A61K 36/71 Loading...
A61K 36/71
Loading...
200910228130.X
Tianjin Tasly Pharmaceutical Co., Ltd.
Yan Lulu
A61K 36/71
Loading...
The invention relates to a lactogenic traditional Chinese medicine composition and a preparation method thereof. The composition consists of radix bupleuri, radix paeoniae alba, scutellaria baicalensis, radix rhapontici, tetrapanax papyriferus, ligusticum wallichii and the seed of cowherb.
193. 102048647 Rotary alternate pill collecting mechanism of pill dropping machine and pill dropping machine thereof
CN
11.05.2011
A61J 3/06 Loading...
A61J 3/06
Loading...
200910228136.7
Tianjin Tasly Pharmaceutical Co., Ltd.
Jin Donghui
A61J 3/06
Loading...
The invention relates to a rotary alternate pill collecting mechanism of a pill dropping machine and the pill dropping machine thereof. The rotary alternate pill collecting mechanism of the pill dropping machine comprises an oil outlet pipe and a multilayer screen frame which is arranged below an orifice of the oil outlet pipe, wherein the multilayer screen frame is detachably arranged on a supporting frame; and one end of the supporting frame is fixed on a rotating shaft and rotates around the rotating shaft. The rotary alternate pill collecting mechanism has a simple structure; oil pills are separated and dropped pills are collected in a semiautomatic control mode without the arrangement of extra equipment; and the rotary alternate pill collecting mechanism has high collection efficiency, and is fast and convenient to use and easy to wash and clean.
194. 102048645 Dropping tank separating and cleaning device of pill dropping machine
CN
11.05.2011
A61J 3/06 Loading...
A61J 3/06
Loading...
200910228134.8
Tianjin Tasly Pharmaceutical Co., Ltd.
Jin Donghui
A61J 3/06
Loading...
The invention discloses a dropping tank separating and cleaning device of a pill dropping machine, which comprises a dropping tank, wherein the dropping tank comprises a tank body and a tank cover which is arranged above the tank body, the tank cover is provided with a rotating shaft, the input end of the rotating shaft is connected with an output shaft of a mixing motor, the mixing motor is fixed on one end of a rotary bracket, the output shaft of the mixing motor is convexly arranged towards the dropping tank direction, the other end of the rotary bracket is fixed on a locating brace through a fastening handle, the fastening handle drives the rotary bracket to rotate around the locating brace as the center, the output shaft of the mixing motor and the input shaft of the rotating shaft are matched mutually through a concave-convex spindle nose structure arranged correspondingly, the output shaft is inserted or extracted along the radial direction of the input end to ensure that the input end and the output shaft are combined or separated; and a water receiving tray capable of being assembled and disassembled is arranged below the dropping tank. The rapidly combined and separated concave-convex spindle nose transmission structure is adopted in the invention, thus the accurate centering rotation is realized, safe and close online cleaning is realized through a labyrinth rotary groove, and a hanging groove and the water receiving tray are convenient for disassembly and assembly.
195. 102048644 Dropping head and special fastening screw driver thereof
CN
11.05.2011
A61J 3/06 Loading...
A61J 3/06
Loading...
200910228133.3
Tianjin Tasly Pharmaceutical Co., Ltd.
Jin Donghui
A61J 3/06
Loading...
The invention discloses a dropping head which comprises a dropping head body, wherein a cavity for containing feed liquid is arranged in the dropping head body; the tail end of the dropping head body is provided with a dropping nozzle pan; a dropping nozzle protrudes outward from the centre of the dropping nozzle pan; a through hole is arranged in the dropping nozzle and passes through the dropping nozzle pan to be communicated with the cavity in the dropping head body; two through grooves are arranged on the dropping nozzle pan in parallel at an interval; the dropping head body is externally provided with a thread connecting the dropping head to a dropping head sleeve; the special fastening screw driver of the dropping head comprises a screw driver head and a screw driver body; the screw driver head comprises two parallel sheet bodies; the top end of the sheet body is a free end, and the root part is connected with the screw driver body and sinks toward the screw driver body to form an opening; the shape and size of the sheet bodies correspond to the shape and size of the through grooves; and the depth of the opening is greater than the length of the dropping nozzle protruding from the surface of the dropping nozzle pan. The dropping head disclosed by the invention has a simple structure, is convenient to operate without interference and can be effectively fixed on a dropping tank.
196. 102038715 Traditional Chinese medicine dispersible tablet and preparation method thereof
CN
04.05.2011
A61K 9/20 Loading...
A61K 9/20
Loading...
200910070826.4
Tianjin Tasly Pharmaceutical Co., Ltd.
Yang Jianhui
A61K 9/20
Loading...
The invention relates to a traditional Chinese medicine (TCM) dispersible tablet and the preparation method thereof, wherein the TCM dispersible tablet contains fine powder or extract of Chinese medicinal materials, water soluble accessories having low melting points, glidants and lubricants. The preparation method thereof comprises the steps of 1). evenly mixing the fine powder or extract fine powder of Chinese medicinal materials with water soluble accessories having low melting points and glidants, adding lubricants into and evenly mixing the mixture for further use; 2) pressing evenly mixed fine power obtained from step 1 into tablets. The TCM dispersible tablet is instantly dispersible, and has a stable quality, and is easy for storing and administration. And, the administration dose is small. The mixture of fine powder or extract fine powder of Chinese medicinal materials with water soluble accessories having low melting points and glidants has excellent flowability, which satisfies the requirement of directly pressing powder into tablets and makes the tablet easy to manufacture.
197. 102018940 Composition with lactogenic effect and preparation method and application thereof
CN
20.04.2011
A61K 36/9068 Loading...
A61K 36/9068
Loading...
200910070443.7
Tianjin Tasly Pharmaceutical Co., Ltd.
Zhu Yonghong
A61K 36/9068
Loading...
The invention discloses a composition with lactogenic effect and a preparation method and application thereof. The composition consists of the following components in part by weight: 5 to 25 parts of Chinese angelica, 3 to 12 parts of Szechuan lovage rhizome, 2 to 6 parts of peach seed, 0.5 to 4 parts of blast-fried dried ginger, 5 to 20 parts of astragalus root, 1 to 6 parts of platycodon root and 0.5 to 4 parts of mix-fried licorice. The composition can remarkably increase the milk secretion quantity of milk lacking female mice, and can remarkably increase the serum prolactin content and hypothalamus 5-hydroxytryptamine content of the milk lacking animals so that the mammary tissues are in a high milk secretion state.
198. 101966220 Panaxtrial saponin extract and preparation process thereof
CN
09.02.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910069902.X
Tianjin Tasly Pharmaceutical Co., Ltd.
Wang Yu
A61K 36/258
Loading...
The invention discloses panaxtrial saponin extract and a preparation process thereof. An extract Rg1(C42H72O14) accounts for 40 to 70 percent of the total extract; notoginsenoside R1(C47H80O18) accounts for 10 to 30 percent of the total extract; and ginsenoside Re(C48H82O18) accounts for 5 to 10 percent of the total extract. The preparation method of the extract comprises: leaching the raw materials with ethanol; concentrating extract; centrifuging concentrate; drying; passing through a neutral alumina column; eluting with an organic solvent; concentrating eluent; treating concentrate with macroporous anion exchange resin; collecting effluent and eluent; concentrating under reduced pressure to dryness; and obtaining the panaxtrial saponin extract. The extract of the invention has high purity, remarkable treatment effect and stable quality; and the preparation method has desirable separation effect and high yield, makes operation convenient, requires low cost and is suitable for industrial production.
199. 101966213 Extracts of panaxtriol saponins and preparation process thereof
CN
09.02.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910069895.3
Tianjin Tasly Pharmaceutical Co., Ltd.
Li Ruiming
A61K 36/258
Loading...
The invention relates to extracts of traditional Chinese medicines and preparation thereof, in particular to extracts of panaxtriol saponins, extracts of panax notoginseng and preparation thereof. The preparation process comprises the steps of extraction, separation, concentration and the like.
200. 101966219 Pseudoginseng root trialcohol group saponin extract and preparation process thereof
CN
09.02.2011
A61K 36/258 Loading...
A61K 36/258
Loading...
200910069901.5
Tianjin Tasly Pharmaceutical Co., Ltd.
Li Ruiming
A61K 36/258
Loading...
The invention discloses a pseudoginseng root trialcohol group saponin extract and a preparation process thereof. An extract Rg1 (C42H72O14) accounts for 40 to 70 percent of a total extract, notoginsenoside R1 (C47H80O18) accounts for 10 to 30 percent of the total extract and ginsenoside Re (C48H82O18) accounts for 5 to 10 percent of the total extract. The preparation method of the extract comprises the following steps of: extracting a raw material with ethanol; concentrating extracting solution; centrifuging the concentrated solution; treating supernate with macropore weakly polar resin; collecting 30 to 40 percent ethanol eluent; and concentrating the ethanol eluent and loading the concentrated ethanol eluent to a decolorizing resin for treatment so as to obtain the pseudoginseng root trialcohol group saponin extract. The extract of the invention has high purity, good curative effect and stable quality. Simultaneously, the preparation method has good separation effect, high content, simple process and low cost and is convenient to operate and suitable for industrialized production.

